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ABSTRACT 
Diet patterns commonly used in epidemiological research are derived using different 
methods, yet there have been few studies assessing if and how research results may vary 
in the same population across diet patterns.  
This study assesses and compares five different diet patterns identified by Principal 
Component Analysis (PCA), Cluster Analysis (CA), Alternate Mediterranean Diet (Alt-
Med), Dietary Inflammation Index (DII), and Recommended Food Score (RFS). 
Colorectal cancer risk and patient’s survival is estimated using different patterns as an 
independent variable. Comparisons are made using hazards ratio, correlation coefficients 
and distributions of individuals in clusters.  
Disease outcome estimation varied with diet patterns used and is mainly attributed to 
differences in its foundation. Hazards ratios for DFS varied from 1.82; (95% CI- 1.07-
3.09) for processed meat pattern identified by PCA to HR 2.19; (95% CI 1.03-4.67) for 
cluster characterized by meat and dairy products and HR 1.95; (95% CI 1.13-3.37) for 
cluster characterized by refined grains, sugar, soft drinks. Only cluster characterized by 
refined grains, sugar, soft drinks had higher risk of OS (HR 2.05; 95% CI 1.18-3.57). All 
the diet indices showed similar null associations with both DFS and OS except Poor 
adherence to altMED increased the risk of all-cause mortality (HR 1.62; 95% CI 1.04-
2.56).  
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Organization of thesis   
This thesis is written in a manuscript format. The thesis has four major chapters. Chapter 
1 is an overall introduction and overview of the study. Chapter 2 and chapter 3 are two 
separate manuscripts. The format of the manuscript is according to the Journal in which it 
has been published or where it is being submitted for publication. Chapter 4 is an overall 
summary of the study. Some duplication in the background, a methodology was 
unavoidable.  
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CHAPTER 1: INTRODUCTION AND OVERVIEW 
 
1.1 Background 
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide (1). It is 
the third most common cancer in men and the second most common amongst women (2). 
Incidence and mortality rates of CRC vary widely with higher incidence rates in 
developed nations and lower rates in  Asia, Africa, and many Latin American countries 
(2). CRC is one of the major health problems of increasing significance in Canada, with 
an estimated 25,100 new cases, and 9,300 deaths in 2015 (3, 4).   According to the 
Canadian Cancer Society, Newfoundland and Labrador (NL), has the highest incidence 
rate of CRC in Canada at 86 per 100,000 compared to the national average of 62 per 
100,000 (4).  The high rates of the disease in NL can only be partly explained by a high 
prevalence of families with a predisposition to hereditary colon cancer (5). Environmental 
factors play an important role in the risk and the progression of CRC (6-10). 
The aetiology of CRC is complex, with both genetic and environmental factors, playing 
an important role. Genetic predisposition (11), age (12) and gender (13) are non-
modifiable risk factors while a lower level of physical activity, western diet, higher 
alcohol consumption, and  smoking and are modifiable factors associated with risk of 
colorectal cancer (14).   
Diet and behavioural factors have an important role in the risk and progression of 
different chronic diseases including CRC (15).  Some studies suggest that diet plays a 
significant role in the regulation of chronic inflammation (16) by altering blood 
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inflammatory biomarkers (17). The Inflammatory microenvironment involves the 
production of cytokines and chemokines leading to tumour initiation, growth, and 
invasion (18) by activating signalling pathways favouring carcinogenesis (19) and is 
particularly of significance in CRC and other epithelial cancers (20).  Refined and 
processed foods, red meat and the western pattern diet in general, have been said to have 
higher inflammatory potential (21) while a prudent diet with higher fruits and vegetables 
may be anti-inflammatory in action (22).  
Epidemiological studies on the role of individual nutrients or food items on disease 
outcome are often inconclusive, which may in part be due to dietary interactions, 
multicollinearity (23, 24) and inability to detect small effects (25). Assessing diet pattern 
have emerged as a possible approach in nutritional epidemiology to explore the combined 
effects of dietary habits total diet on health (26). Diet patterns not only represent total diet 
or key factors in the diet (27) and the frequency of its consumption but also reflect an 
individual’s food preferences modulated by the combination of genetic, cultural, social, 
health, environmental, behavioural and economic determinants (28).  
Data-driven and hypothesis-driven are two major approaches that are used in literature to 
identify diet patterns (29). The former solely reply on inter-correlations among the food 
items and latter allows the researcher to incorporate their professional knowledge and 
understanding. Cluster and factor analysis are outcomes independent empirical data-
driven/posterior techniques determining dietary behaviour in the study population while 
index/score-based are hypothesis-driven based on adherence to prior recommendations or 
guidelines (30). Briefly, cluster analysis (CA) separates individuals into mutually 
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exclusive, non-overlapping groups based on mean dietary intakes. Food intake common 
to all individuals contributes less to cluster formation. Optimal clusters are formed by the 
maximum ratio of variance across the cluster to within the cluster. No gradient is formed 
hence comparison is done with the reference cluster. Factorial analysis, specifically 
Principal Component Analysis (PCA), an exploratory approach, reduces a large set of 
correlated variables to smaller sets of non-correlated variables which capture the majority 
of dietary variations within the study population. Linear combinations are created and 
each individual receives a score called factors (31). A higher score represents higher 
adherence to the particular diet pattern.  
Recommended food score (RFS) (32) and alternate Mediterranean diet score (Alt-Med) 
(33) are commonly used index-based diet patterns for which scoring is based on 
adherence to a set of dietary guideline or to the Mediterranean diet, respectively. The  
Dietary Inflammatory Index score (DII) (34) is based on each nutrient’s response to six 
inflammatory biomarkers. The DII allows the dietary intake to classify as pro-
inflammatory vs. anti-inflammatory. For such indices, patterns are derived from gradients 
which are then compared by referring to reference quartiles.  
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1.2 Rationale of Study 
Different diet patterns commonly used in nutrition epidemiological research can be 
derived using different methods, yet there have been few studies assessing if and how 
research results may vary in the same population when different methods are used. 
Comparing across these diet patterns identified by the various methods is recommended 
to better understand the association between disease and diet (35).  
This study aims to assess and compare various different diet patterns while estimating the 
CRC risk and patient’s survival using Newfoundland Colorectal Cancer Cohort. 
Newfoundland and Labrador have the highest age-adjusted incidence of CRC compared 
to rest of Canada and unique dietary patterns which makes it an ideal environment in 
which to study this association.  
1.3 Study Objectives 
1. To identify various diet patterns by Principal Component Analysis, Cluster Analysis, 
Recommended Food Score, Alternate Mediterranean Diet Score and Dietary 
Inflammation Index score 
2. To estimate the patient’s survival amongst these diet patterns 
3. To investigate the association of dietary inflammation on the risk of CRC 
4. To compare various diet patterns  
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1.4   Literature Review 
1.4.1 Incidence and mortality of colorectal cancer 
Colorectal cancer is the third most common cancer in men and the second most common 
cancer in women. In 2012, worldwide, it was estimated that 746 000 new cases were 
diagnosed in men (10% of all incident cancer cases in men) and 614 000 new cases in 
women (9.2% of all incident cancer cases in women). Amongst them, more than half 
were in developed countries. There is substantial geographical variation in incidence 
across the world. The highest age-standardized incidence rates (per 100 000 population) 
estimated 2012 were in Australia/New Zealand (44.8 and 32.2 cases in men and women, 
respectively), and the lowest was in western Africa (4.5 and 3.8 cases in men and women, 
respectively) (36).  
Mortality is considerably lower than incidence rate, with an estimated 694 000 CRC 
deaths in 2012 (8.5% of all cancer deaths that year) due to improved early diagnosis and 
treatment.  More than half of CRC deaths in 2012 were from low-income countries, 
reflecting poorer survival in these regions. Worldwide, mortality rates vary less than 
incidence rates. In both sexes, the highest estimated 2012 mortality rates (per 100 000 
population) were in central and eastern Europe (20.3 deaths in men and 11.7 in women), 
and the lowest in western Africa (3.5 deaths in men and 3.0 in women) probably due to 
poor reporting. (36) 
In Canada, 25,100 new cases, and 9,300 deaths were estimated attributed to CRC (3, 4) in 
2015.   According to the Canadian Cancer Society, Newfoundland and Labrador (NL), has 
the highest age-standardized incidence rate of CRC in Canada at 86 per 100,000 
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compared to the national average of 62 per 100,000 (4). Approximately 540 patients are 
diagnosed with CRC in NL every year. 
1.4.2 Pathogenesis of CRC 
Colorectal cancer develops through a gradual accumulation of inherited, somatic, and 
epigenetic changes, leading to the transformation of normal colonic mucosa into invasive 
cancer cells. Risk of CRC increases with age,  by certain high penetrance inherited 
genetic mutations (familial adenomatous polyposis and hereditary non-polyposis 
colorectal cancer), several low penetrance mutations (37), and a personal or family 
history of colorectal neoplasia/ inflammatory bowel diseases (38). Several modifiable 
factors are also associated with increased risk of CRC including obesity,  diet pattern, 
physical inactivity, smoking, heavy alcohol consumption, type II diabetes, and of aspirin 
or other non-steroidal anti-inflammatory drugs (NSAIDs) (39). 
1.4.3 Role of Inflammatory cytokines in cancer and chronic diseases 
Chronic inflammation is considered to be a hallmark of the causation of cancer and 
inflammation is mediated by different cytokines (40). Cytokines are broad categories of 
small proteins that are important in cell signalling. Cytokines include chemokines, 
interferons, interleukins, lymphokines and tumour necrosis factors. Cytokines are 
produced by a broad range of cells, including immune cells like macrophages, B 
lymphocytes, T- lymphocytes and mast cells, as well as endothelial cells, fibroblasts, and 
various stroma cells (41). Cytokines are involved in leukocyte recruitment and have both 
synergistic as well as antagonistic interactions with various target cells (42). Although 
produced by a wide variety of cell types, macrophages and T lymphocytes (T cells) are 
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the primary producers of cytokines; they have predominantly pro-inflammatory 
(inflammation-promoting; IL1α, IL1β, IL2, IL6, IL8, IL12, TNFα, IFNγ;  or anti-
inflammatory (inflammation-suppressive; IL4, IL5, IL10, TGFβ) abilities (43).Several 
studies have suggested associations between inflammation and cancer development (44). 
Diet can play an important role in the regulation of chronic inflammation (16) by altering 
blood inflammatory biomarkers (17) 
1.4.3.1 Pro-inflammatory cytokines 
C-Reactive proteins (CRP) 
 
CRP is an acute-phase protein found in the blood and synthesized in the liver in response 
to inflammation. Several prospective studies have demonstrated an association of  CRP 
with chronic diseases/conditions and patient survival (45) though the results are often 
inconsistent. Pancreatic, oesophageal, and prostate cancers especially have been 
suggested to be associated with CRP levels (46).  Association of CRP with CRC is 
inconclusive. A meta-analysis of 8-prospective studies showed that increased baseline 
CRP levels were associated with a modest risk of CRC (47) whereas the other nested 
case-control study showed a reduction in risk of developing CRC (17). Due to its short 
half-life, and the fact that different acute and chronic conditions are possibly associated 
with CRP levels. It is challenging to assess exact amounts of CRP in the blood (46). 
TNF-α 
TNF- α is a signalling protein involved in the systemic inflammation produced by 
activated macrophages and other cell types such as lymphocytes, NK cells, neutrophils, 
mast cells, eosinophils and neurons.  It promotes the inflammatory response by different 
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mechanisms. In the liver it stimulates acute-phase proteins, leading to an increase in CRP 
levels. It also induces insulin resistance by binding to insulin receptor substrate -1 (IRS-1) 
which impairs insulin signalling. On macrophages, it stimulates phagocytosis and 
production of other inflammatory cytokines, IL-1 and prostaglandins. It has been 
suggested that consumption of  Dietary fibres, vegetable oil rich in omega 3 can inhibit 
the synthesis of TNF-α (48, 49). 
IL-1B 
An IL-1 family is a group of 11 cytokines, which induce a complex network of pro-
inflammatory cytokines via the expression of integrins on leukocytes and endothelial 
cells; they regulate and initiates inflammatory responses (50). Secretion of IL-1 is 
inhibited by fatty acid  Omega-3 (48) 
IL-6 
Interleukin 6 is secreted by T cells and macrophages to stimulate the immune response, 
during infection and after trauma, especially with burns or other damaged tissue leading 
to inflammation. IL-6 together with other cytokines help to activate T cells, increase the 
number of antibody-producing B-cells and stimulate the release of hormones. However, 
the prolonged release of IL-6 causes premature death of immune cells ultimately leading 
to increased risk of tumour growth (51). High-fat diets have been found to be associated 
with increase in IL-6 (52) whereas  Vitamin E, D, Omega-3 fatty acids  have been shown 
to oppose the action of with IL-6 (53, 54)  
 
	
	
9	
	
 
Figure 1 Role of inflammation in the cancer progression (46) 
As seen in the figure 1; external stimuli including environmental, dietary, occupational 
exposures, energy imbalance and any other chronic conditions are responsible for genetic 
variations and activating the immune effectors. Both of this processes are associated with 
the tumor initiation by initiating antiapoptosis, increased angiogenesis and genomic 
instability. Further, this leads to immune suppression, metastasis, additional genomic 
instability and angiogenesis (46).  
1.4.3.2   Anti-inflammatory cytokines 
 
IL-4  
Interleukin-4 modulates inflammation and is associated with colorectal adenoma 
carcinoma progression and metastatic capacity. They are believed to reduce proliferation 
and arrest cell migration in a dose-response manner (55). Further, it has been suggested 
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that  IL-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis 
which in turn may reduce the risk of obesity (56). 
IL-10 
IL-10 is an anti-inflammatory also known as human cytokine synthesis inhibitory factor 
(CSIF). IL-10 is a cytokine with multiple, pleiotropic, effects in immune-regulation and 
inflammation. It down-regulates the expression of Th1 cytokines, MHC class II antigens, 
and co-stimulatory molecules on macrophages. It also enhances B cell survival, 
proliferation, and antibody production. IL-10 can block NF-κB activity and is involved in 
regulation of the JAK-STAT signalling pathway (57). 
1.4.4 Factors Associated with the risk of Colorectal Cancer 
The aetiology of CRC is complex and multi-factorial (58).  Approximately 15% to 20% 
of all CRCs are familial, and several heritable risk factors and CRC susceptibility genes 
are involved (59).  Majority of CRC cases are sporadic; they arise through cumulative 
effects of environmental factors and complex interaction between heritable genetic and 
environmental components (60). 
1.4.4.1 Non-modifiable risk factor for CRC 
1.4.4.1.1 Family History   
 
The family history of CRC is seen to increase the risk of CRC by two to four times (61). 
The risk is higher among people whose relatives were diagnosed before  50 years of age 
(62). A family history of CRC may increase CRC risk by influencing the adenoma growth 
or enhancing the formation of new lesions. For early diagnosis and treatment, the 
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American Cancer Society, the US Multi-Society Task Force on CRC, and the American 
College of Radiology recommends on early screening for individuals with a family 
history of CRC (63). 
Familial adenomatous polyposis (FAP, 1% of all CRC cases) and hereditary non-
polyposis CRC(HNPCC, 5%-7% of all CRC cases) are attributed to familial risk (64) and 
are inherited in an autosomal dominant fashion. FAP is caused by inactivating mutation 
of a tumour suppressor gene, the adenomatous polyposis coli (APC) gene. Patients 
affected by FAP usually present with hundreds of adenomatous polyps in the colon, 
which will inevitability transform to carcinoma if left untreated (65). HNPCC results 
from mutations in mismatch repair genes, commonly MLH1, MSH2 and MSH6 (65). 
More than 90% tumours arising in HNPCC patients show microsatellite instability (65). 
1.4.4.1.2 Age 
 
Advanced age is one of the most important risk factors for colorectal cancer. According 
to the American Cancer Society, almost 90% of CRC is diagnosed after the age of 50 
years. One of the possible mechanisms is an accumulation of age-associated changes in 
the biochemical processes that help to control the genes responsible for increased risk of 
cancer. Advancing age is seen to be linked with increased methylation (66). 
1.4.4.1.3 Sex 
 
Risk of CRC is considerably higher in men compared to women (67). Epidemiological 
studies involving females have shown that increases in female hormones like estrogens 
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and progestin due to pregnancy or use of exogenous hormones could be associated with a 
lower risk of CRC (68). However, inconsistencies do exist in these studies (69). Lower 
androgen levels have been hypothesized to increase the risk of CRC in male (70).  
Further, differential levels of environmental exposures including smoking, alcohol, and 
diet patterns intake make men more vulnerable to the development of CRC. 
1.4.4.1.4 History of inflammatory disease 
 
History of inflammatory bowel disease (IBD) including ulcerative colitis and Crohn’s 
disease increases the risk of CRC. Dysplasia is a condition where cells in the lining of the 
colon and rectum change to abnormal cells due to untreated IBD. Although, these are not 
true cancer cells they are likely to transform to cancerous cells over time hence early 
screening is recommended. 
1.4.4.2 Modifiable Environmental Factors  
 
Different environmental factors have been studied as potential risk factors for CRC both 
experimentally and epidemiologically. These include dietary factors, physical activity, 
overweight and obesity, smoking, intake of alcohol, use of inflammatory drugs, and 
reproductive hormone therapy (HRT) in females.  
1.4.4.2.1 Dietary Factors 
 
Diet has been shown to be associated with risk of CRC through a number of possible 
routes, including physical interaction with the intestinal mucosa (71), alterations in the 
intestinal microbiota, which are strongly associated with colonic polyp formation (72), or 
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influence on certain biomarkers in the body. It is estimated that almost 70% of cancer 
burden could be reduced by alterations in dietary habits (73) 
 Total Energy and Macronutrients 
Total energy intake is seen to be associated with risk of CRC (74-76).  Though the 
underlying biological mechanisms are not fully understood, it is suggested that high 
energy intake could induce glycaemic overload which increases serum insulin and insulin 
growth factor-1 (IGF-1), which in turn may promote cell proliferation, inhibit apoptosis, 
and eventually elevate the risk of colorectal tumorigenesis (77-80). 
Fruits and Vegetables 
 
Over 20 case-control (81) and 7 cohort studies (82) have suggested that a high 
consumption of fruits and vegetables may be associated with a reduction in CRC risk. A 
protective effect was found for total fruit and vegetable consumption in the 9.6-year 
follow up of the Swedish Mammography Screening Cohort Study (82). A meta-analysis 
(83) has suggested that dietary fibre may protect against CRC, although results from 
prospective cohort studies (84-86) have been negative. The probable reason might be, the 
protective effect of dietary fibre may require a much longer response latency than the 
follow-up time frame of the research studies (87). 
Dietary fibre 
Dietary fibre decreases the risk of CRC by accelerating the transit of gastrointestinal 
contents, reducing the colonic exposure time to multiple exogenous and endogenous 
carcinogens (88).Meanwhile, fibres promote the fermentation of food particles in colon 
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leading to the production of short-chain fatty acids, butyrate a mediator of anti-
inflammatory response in the colonic epithelial cells. Phytochemicals are involved in the 
prevention of oxidative DNA damage, DNA correction mechanism or binding of 
carcinogens (89).  
Red and Processed Meat 
 
“Red meat” is generally defined as flesh from some domesticated animals, which is 
mainly comprised of red muscle fibres, such as beef, pork, lamb and goat. Red meat is red 
when it is raw and dark when cooked while white meat is pale in colour before and after 
cooking.  “Processed meat” refers to meats preserved by smoking, curing, or salting, to 
which nitrites/nitrates or other preservatives are artificially added, such as ham, bacon, 
and salami (90).  
A study reviewed by the 2007 WCRF/AICR panel (90) reported an increased risk for 
individuals in the highest intake group relative to those in the lowest (based on quartiles), 
and an apparent dose-response effect has been observed. As well, 12 out of 14 cohort 
studies  (90)  have shown a positive association between processed meat intake and CRC 
risk, with the association being statistically significant in four (91-94). A meta-analysis of 
five studies showed the relative risk of 1.21 (95% CI 1.04-1.42) per 50 g/day augment of 
processed meat intake (90). Similarly, a recent meta-analysis of 15 prospective studies, 
which indicated that a daily increase in red meat consumption by120 gram is associated 
with a 28% (95%CI: 18%-39% ) increase in CRC risk (95).  
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There are several possible mechanisms that may explain the associations observed 
between red/processed meat and CRC. First, meat fried or cooked at high-temperatures 
may contain carcinogenic heterocyclic amines and polycyclic aromatic hydrocarbons 
(90). Many processed types of meats are also high in salt, nitrites, and nitrates which may 
subsequently promote the formation of endogenous N-nitroso compounds; these 
compounds are suspected human carcinogens and have been suggested as significant 
contributors of CRC development (96, 97), Moreover, high consumption of red meat has 
been associated with increased iron level, which acts as a possible catalyst to stimulate 
the production of reactive oxygen species, and hence resulting in DNA damage (98, 99). 
Minerals and Vitamins 
 
Several antioxidants such as beta-carotene, riboflavin, folate, and vitamins A, C and D 
have long been regarded as natural inhibitors that retard cancer initiation or progression 
(100-104). Since these antioxidants can provide antioxidant and anti-inflammatory 
effects, it is suggested they protect against CRC. In addition, the vitamins could modulate 
Treg function and IL-10 production which are important for therapeutic treatment. 
Vitamin A increases inflammatory response and is involved in tissue damage; moreover, 
vitamin A is a key modulator of TGF-beta which can suppress several cytokines. Vitamin 
E, an anti-ageing compound, is associated with a defect of naive T cells and may inhibit 
some inflammatory compounds such as prostaglandin (105). 
In addition, dietary calcium and selenium have consistently been associated with a lower 
risk of CRC, whereas dietary iron has increased the risk of CRC because of its catalytic 
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activity on the production of oxygen radicals (101,106). The dosage of these minerals and 
vitamin plays a vital role in its action.  
Milk and dairy products 
 
Epidemiological studies on milk and risk of CRC have mixed results. High calcium 
content in milk could potentially bind with inflammatory cytokines and thereby reduce 
cell proliferation and promote cell differentiation (107). On the other hand, the high fat 
content of milk is likely to increase the risk of CRC by increasing bile acid in the colon 
(108).  
Spices 
 
A growing body of epidemiological and pre-clinical evidence suggests that spices have 
multiple anticancer properties (109). Capsaicin, a compound present in hot pepper has 
been seen to activate apoptosis of the cancerous cells (110).  Similarly, turmeric 
(curcumin), cloves (eugenol), ginger (zerumbone), fennel (anethole), kokum (gambogic 
acid), fenugreek (diosgenin), and black cumin (thymoquinone) appear to have a role in 
cancer prevention (111). Spices inhibit the synthesis of inflammatory cytokines; they 
interfere with signalling mechanisms (STAT 3) and gene expressions, work as analogues 
with the animal sterols (112). Their concentration is vital. 
1.4.4.2.2 Cigarette smoking 
There are many studies that report a positive association between chronic smoking and 
elevated risk of CRC (113-120). Risk increases in a dose-dependent manner (113, 114, 
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116, 117).  A meta-analysis  (121) suggested that ever smoking was associated with an 
almost 20% increase in CRC risk compared with never smoking. Risk estimate varied 
with the location of cancer and as higher for cancer of the rectum than of the colon in 
current smokers. Tsoi et al. (122) reported that current smokers carried a moderately 
higher risk of CRC relative to never smokers, and the increased risk of CRC was dose-
related to higher levels of daily cigarette consumption/pack-years, and longer years of 
smoking. Among studies that assessed the effect of smoking cessation on CRC risk, three 
(120, 123, 124) reported no consistent trend in risk whereas other two (119, 125) reported 
significantly increased risk with prolonged cessation time.  
Different carcinogens are known to be present in cigarette smoke such as polycyclic 
aromatic hydrocarbons and aromatic amines (126-128) which may reach the bowel 
mucosa through direct ingestion (129) or through the circulatory system (130), thus 
exerting growth-promoting effects on cancer cells in the colon/rectum and increasing 
CRC incidence. Second, tobacco smoking may cause mutation of the GSTM1 gene, 
resulting in further impaired detoxification of these carcinogens (131). Moreover, 
smoking may also induce aberrant promoter DNA methylation, thus silencing regulatory 
genes (e.g., ECAD, p16, MGMT, and DAPK) in tumour initiation and promotion (132). 
1.4.4.2.3Physical Activity Levels 
Physical inactivity is an established risk factor associated with CRC that is independent of 
other variables, including obesity (71). Physical activity is believed improve the body’s 
metabolic efficiency and reduces blood pressure and insulin resistance. Most of the 
epidemiological studies investigating the physical activity and CRC demonstrated a 
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decreased risk of developing the disease with increased habitual levels of physical 
activity, except for one early study that reported a positive but non-significant association 
between physical activity and CRC among men aged <45 years (133). It is estimated that 
high habitual levels of physical activity could reduce up to 50% of all incidents of CRC 
(134), and engage in two hours or more of physical activity per week could significantly 
reduce CRC risk in most people (135). 
1.4.5   Factors Associated with Colorectal Cancer Survival  
Colorectal cancer survival is mainly associated with stage at diagnosis and histological 
grade of disease. Generally, earlier the diagnosis, longer the survival. Similarly, lifestyle 
and behavioural factors affect the survival of CRC patients. Healthier lifestyle before the 
cancer diagnosis is associated with improved overall survival after CRC diagnosis (136) 
despite some inconsistencies seen across studies due to limited follow-up duration, 
sample size and/or methodological issues.  
 There is enormous variability in CRC survival worldwide. The geographical differences 
in survival may be in part due to global/regional inequalities in prompt cancer detection 
and treatment of disease (137). However, survival for CRC at all stages has increased in 
recent years (137, 138). 
1.4.5.1 Non-modifiable factors 
 
Most known factors that influence CRC survival are clinical pathologic features which 
are unmodifiable, including tumour stage, histological grade, treatments received, and 
tumour molecular phenotype. Tumour stage and histological grade of CRC are 
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particularly of importance in the severity of disease and chance of survival. The 5-year 
survival rate was estimated at over 90% for tumours detected at the localized stage; 70% 
for regional, and only 10% for people diagnosed with distant metastatic CRC (138). For 
metastatic CRCs, a systemic treatment appears to largely lengthen the median survival 
time  (139). Further, there is some evidence that associations exist between a tumour 
molecular features and survival. MSI-H CRCs has been linked to an excellent 5-year 
survival, while BRAF-mutant tumours have a poor survival (140-142).	 
1.4.5.2. Modifiable risk factors 
 
1.4.5.2.1 Dietary factors 
Diet and nutritional factors are widely believed to act as pro- and antitumor risk modifiers 
across the entire multi-step process of colorectal tumorigenesis, which includes tumour 
initiation, promotion and progression. Differences in the rates of CRC by country, and the 
elevated risks amongst new migrants from a low to the high-risk country, strongly support 
the importance of environmental factors in CRC risk (143). 
Diet has been an important determinant for the survival of colorectal cancer. Several 
epidemiological studies discussed the role of diet in risk and survival of CRC.  
Total Energy and Macronutrients 
Epidemiological evidence on the association between intake of total energy and CRC 
survival remains controversial. Dray et al. (144) analyzed 10-year survival data on 148 
patients who received resection of the tumor and concluded that high energy intake, 
resulting from high intakes of carbohydrate, protein, and lipid, was strongly associated 
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with better 5-year survival (HRs 0.18) in comparison to the lowest tertiles. Likewise,  a 
study by Slattery et al. (145)  showed that the highest quartile of intake for total calories, 
fat and protein was associated with increased cancer survival. While some recent studies 
have shown contradicting results. For example, one study (146) showed an adverse 
impact of a diet high in carbohydrates on disease-free survival, recurrence-free survival, 
and overall survival of colon cancer patients. Similarly, Sichieri et al. (147) found that 
total fat intake was positively associated with CRC mortality. The contradictory results 
are likely to be a consequence of causal or residual confounding factors such as disease 
stage at diagnosis that had not been adjusted for in earlier studies.  
Fruits and Vegetables 
Diets higher in fruit and vegetables tend to be associated with a lower risk of CRC 
mortality (148). The favourable roles of fruit and vegetables on CRC progression may be 
attributable not only to the antioxidant vitamins or anti-inflammatory potential but also to 
their fibre content. An ecological analysis of Seven-Country Study (149) showed a strong 
inverse association between dietary fibre and CRC mortality. Similarly, the Cancer 
Prevention Study II conducted by researchers from American Cancer Society also 
observed inverse associations between certain fruits rich in fibre and the risk of fatal CRC 
(150, 151).	 As well, Dray et al. (144) found a significant association between fruit, 
vegetables, and CRC survival.  
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Red and Processed Meat 
Although red and processed meats have been confirmed as a moderate risk factor for 
CRC (152), minimal research has specifically examined to assess its role in patient’s  
survival.  A study by McCullough et al. (153) amongst 2,315 patients with CRC who 
reported both pre- and post-diagnosis diets in the Cancer Prevention Study II Nutrition 
Cohort showed that neither pre- nor post-diagnosis red/processed meat consumption was 
significantly associated with CRC mortality risk; however, individuals with consistently 
high intakes of red/processed meat before and after diagnosis were 1.79 (95%CI: 1.11-
2.89) times more likely to die from CRC than those with consistently low intakes. Similar 
was the observation in the study by Zell et al. (154). A significant interaction was seen 
between family history and red/processed meat in McCullough’s study. High risk of all-
cause mortality was seen in individuals with positive family history.  
Overweight and Obesity 
Overweight and obesity are linked with the risk of several chronic diseases including the 
CRC. Results amongst the females are ambiguous. menopausal status, postmenopausal 
hormone use, and family history of cancer may modify the link between adiposity and 
colorectal cancer. Similarly, obesity is seen to be strongly related to CRC if an individual 
has the family history of CRC. Possible mechanisms involve, obese people has chronic 
low level inflammation, which over the time cause DNA damage that leads to cancer. 
Adipose tissues produce extra amount of estrogen, which has been associated with the 
increased risk of cancers. Obese people has high levels of blood insulin which has been 
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associated with the increased risk of cancer. This has direct effect on the progression of 
cancer too.  
Minerals and Vitamins 
Significant associations have been identified between minerals/vitamins and survival 
from CRC, for example, high premorbid levels of selenium, vitamin B6, retinol, β–
carotene, lycopene, total carotene, and pro-vitamin A are seen to be associated with better 
survival (100, 155-157). However, no consistent trend in risk for death as a result of CRC 
has been observed for any of the aforementioned nutrients in an ecological survey in 49 
Chinese rural counties (148) nor in a study of 16 cohorts of the Seven Countries Study 
(158). A difference in the findings may be associated with different levels of 
consumptions. 
1.4.5.2.2 Cigarette Smoking 
Numerous studies have investigated the role of smoking in CRC survival with conflicting 
findings. Most studies (159-163), but not all (164-166), have indicated that cigarette 
smoking is associated with increased risk of CRC mortality and poor survival, 
specifically for tumors in the rectum than in the colon; however, these associations vary 
in both direction and magnitude. There have been four main studies that assessed the 
effect of smoking cessation on the risk of CRC mortality, two of which have reported 
protective effects of smoking cessation on CRC mortality risk (160, 162). The other two 
(166, 167)have found no significant association. 
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A review of 106 observational studies on cigarette smoking in relation to both CRC 
incidence and mortality by Botteri et al. (121) reported that ever smoking relative to never 
smoking status was linked with a 1.25 times increased risk. Mortality increased linearly 
with increasing number of cigarettes smoked per day and prolonged duration of smoking. 
A study by Liang et al. (168) examined 36 prospective studies and observed almost 40% 
in RR for CRC mortality in current smokers compared to never smokers. For every 
additional 20 cigarettes per day, the risk of CRC mortality increased by 40.7%. Some 
studies have reported non-significant relation in survival rates between smokers and non-
smokers with CRC (164-166)	which might be attributed to the long induction period of 
CRC (121), as well as the potential for modulating effects of important prognostic 
variables (169-171), many of which have not been considered for in those studies.  
1.4.5.2.3 Physical Activity Levels 
Higher levels of physical activity have been associated with a lower risk of CRC 
mortality in many epidemiological studies (172-174). In Cancer Prevention Study-II 
(CPS-II) Nutrition Cohort by Campbell et al. (174) reported protective effects of being 
physically active both before and after a cancer diagnosis. A 2-year follow-up study in 
western Australia showed that lower level of physical activity, being overweight/obese, 
smokers were all associated with poor survival in females but no significant association 
was seen in the males (175). Similarly, evidence from prospective cohort studies (172), 
showed that patients who participated in any amount of physical activity before and after 
diagnosis were found to be at lower risk of CRC-specific mortality compared with 
patients who did not participate in any physical activity.  
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1.4.5.2.4 Inflammatory Drugs 
Long-term use of Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with 
the reduced risk of CRC (176).  NSAIDs are seen to inhibit cell proliferation rate, alter 
cell cycle, and induce apoptosis in colon cancer cell lines (177).  Results suggest that 
optimal chemoprevention for CRC requires long-term use of aspirin doses substantially 
higher than those recommended for prevention of cardiovascular disease (178). 
1.4.6   Diet patterns  
Epidemiological investigations in the field of nutrition have shifted from the level of 
individual nutrients to investigations at the level of foods and diet patterns (179) to 
understand the disease-diet relationship. These combinations of foods, nutrients, or in 
some cases, foods and nutrients, are often intended to represent the total diet or key 
factors of the diet. Several reasons are suggested (30); effects of individual nutrients may 
not be equivalent when foods containing many nutrients are consumed or when foods are 
consumed as part of a larger diet pattern containing many foods, the magnitude of the 
effect of individual nutrients is often too small to overcome the noise of confounding and 
imprecise measurement, whereas the sum effect of many foods may be sufficiently large, 
correlations among nutrients and among foods are often too high to allow their individual 
effects to be accurately determined with traditional statistical approaches.  
Diet patterns can be identified by various methods which can be broadly classified into 
data-driven and investigator-driven techniques. 
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1.4.6.1. Data-driven approaches 
 
Data-driven approaches in diet pattern analyses use mathematics to empirically derive 
eating behaviour patterns using dietary data collected from FFQs, 24-hour recalls, or diet 
records. In factor and cluster analyses, a larger set of dietary variables are aggregated to 
form a smaller set of variables. These methods do not require a prior theory of what 
patterns are expected, although a thorough understanding of the literature on eating 
patterns, in conjunction with a theoretical framework for eating behaviour, can be used. 
Factor Analysis 
 
The most common factor analysis method used in nutritional epidemiology is principal 
components analysis, a form of exploratory factor analysis. PCA does not assume an 
underlying model for the factors and uses matrix algebra to identify the principal 
components in the data, based on a correlation or covariance matrix of the input variables. 
The resulting components, or factors, are linear combinations of the observed variables 
that explain the variance in the data. The factors can be rotated to improve 
interpretability; orthogonal rotation is commonly used. An output from the PCA includes 
factor loadings (or scoring coefficients) for each variable, which can be interpreted as 
correlation coefficients. Factor scores are calculated for each individual by summing the 
standardized input variables, weighted by their factor loadings. Factor scores are often not 
correlated with each other. Factors are not mutually exclusive: individuals receive factor 
scores for each derived factor. Factors are continuous variables that are often categorized 
into quartiles. 
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Cluster Analysis 
 
The purpose of CA is to place individuals into groups, or clusters, suggested by the data, 
not defined a priori, such that objects in a given cluster tend to be similar to each other in 
some sense, and objects in different clusters tend to be dissimilar. Like factor analysis, 
CA is also a multivariate method which can be used for characterizing diet patterns. In 
contrast to factor analysis, CA aggregates individuals into mutually exclusive, non-
overlapping, relatively homogenous subgroups (Clusters) with similar diets. Each 
Individual is positioned in the space and can be classified into distinct clusters or groups 
on the basis of the frequency of food consumed, a percentage of energy contributed by 
each food or food group, the average grams of food intake (182), or a combination of 
dietary and biochemical measures.  
By default, the SAS software FASTCLUS procedure uses Euclidean distances, so the 
cluster centres are based on least squares estimation. This kind of clustering method is 
often called a -means model, since the cluster centres are the means of the observations 
assigned to each cluster when the algorithm is run to complete convergence. Each 
iteration reduces the least squares criterion until convergence is achieved. Food intake 
common to all contributes less to cluster formation. Optimal clusters are formed by the 
maximum ratio of variance across the cluster to within in the cluster. Clusters are 
categories where the variation of individual foods is not considered after classification. 
No gradient is formed and the comparison is done across the clusters. 
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1.4.6.2 Investigator-driven approaches 
 
Score-based approaches are based on dietary recommendations as well as other 
knowledge about the subject matter. These approaches generally fall into four categories: 
nutrient adequacy or density scores, variety or diversity scores, food-group patterning 
scores, and index-based summary scores. 
Nutrient Adequacy scores 
 
Nutrient adequacy scores include the nutrient adequacy ratio, defined as average daily 
intake of a nutrient divided by age- and sex-specific recommended intake of that nutrient, 
and mean adequacy ratios are defined as the sum of the nutrient adequacy ratio divided by 
the number of nutrients having a nutrient adequacy ratio. Nutrient adequacy score is 
developed to evaluate the overall dietary quality of food assistance program. Nutrient 
density scores were created to evaluate the dietary quality of individual foods in terms of 
nutrient content in relation to total energy, but do not evaluate total diet pattern (183).  
Dietary Variety Scores 
 
Dietary variety scores were started after the introduction of dietary guidelines for 
Americans in 1980.  Variety amongst food groups is defined as the mean number of 
different food groups consumed daily and variety within the food groups is defined as the 
mean number of different food subgroups or individual foods within food groups 
consumed daily.  
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Dietary variety refers to the mean number of different food groups consumed daily. It 
considers the number of food groups (i.e. dairy, meat, grain, fruits and vegetables) or food 
items consumed regularly (184).  Both variety amongst the food groups and within a food 
group explains the variation in mean adequacy ratio scores but are not able to explain the 
variation in intake of energy, fat, sugar, sodium or cholesterol. First Nation Health and 
Nutrition Examination Survey have shown that less diverse food groups are associated 
with increased mortality. Similarly, increased variation within the food groups was 
positively associated with energy intake. Increased variation within certain food groups 
e.g. sweets, snacks, condiments and carbohydrates and low variety of fruits and 
vegetables was positively associated with the body fatness (185).  
RFS  tallies the foods recommended by current dietary guidelines (32). The RFS is 
similar to dietary diversity score for recommended foods groups. Currently, dietary 
guidelines encourage the consumption of fruits, vegetables, and whole grains.  
Food Groups Patterning Scores 
 
Food groups patterning scores are based on the five major food groups; fruits, vegetables, 
grains, dairy and meat. Based on the intake of foods from these groups health outcome is 
assessed in the study population.  
Index based summary scores 
 
The diet quality index is a summary score of the degree to which an individual's diet 
conforms to specific dietary recommendations. Dietary index approaches is limited by 
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current knowledge and lack of understanding of the diet-disease relationship. Defining the 
cut-off points is challenging. Typically, dietary indices are constructed on the basis of 
prevailing dietary recommendations, some of which may not represent the best available 
scientific evidence. For example, the healthy eating index is based on adherence to the 
recommendations of the US Department of Agriculture Food Guide Pyramid.  
The Mediterranean diet pattern (MDP), is considered to be one of the healthiest diet 
patterns. The Mediterranean diet is plant-based, where vegetables, fruits, cereals 
(preferably with whole grain), legumes, and nuts are consumed in high amount and 
frequency. MDP also includes moderate consumption of fish and shellfish, white meat, 
eggs, and dairy products. On the contrary, consumption of red meat, processed meats, and 
foods rich in sugars and fats should be small in both quantity and frequency(186). The 
principal source of dietary lipids of the MDP is olive oil and an adequate daily intake of 
water should be guaranteed. A moderate consumption of wine is recommended. MDP 
encloses a beneficial fatty acid profile with a high content of MUFA and a higher 
MUFA/saturated fatty acids (SFA) ratio than non-Mediterranean diets. High consumption 
of dietary fibre, low glycaemic index and glycaemic load, anti-inflammatory effects, and 
antioxidant compounds, may act together to produce favourable effects on health status. 
The DII is a relatively new dietary index that is based on peer-reviewed research focusing 
on diet and inflammation and is standardized to world average dietary intake. Chronic 
inflammation is considered to be the hallmark of the causation and progression of 
multiple cancers epithelial cancers.  DII score is calculated based on the response to six 
inflammatory biomarkers including  IL-1B, IL-6, TNF-α, or CRP (pro-inflammatory) and 
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IL-4 or IL-10 ( anti-inflammatory (34) cytokines. In index based patterns gradients are 
formed and the comparison is done talking the reference quartile. 
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Summary of literature review 
Colorectal cancer is a leading cause of cancer-related deaths worldwide. Etiology of CRC 
is complex and multifactorial. Genetic predisposition (11), age (12) and gender (13) are 
some of the non-modifiable risk factors while the lower level of physical activity, diet 
pattern, higher alcohol consumption, smoking are the common modifiable factor 
associated with risk of CRC (14).   
The dietary factor is considered to be one of the important determinants of cancer (15).  
Diet is associated with risk of CRC through either physical interaction with the intestinal 
mucosa (88) or alterations in the intestinal microbiota, which are strongly associated with 
colonic polyp formation and with the risk of developing CRC (92). Similarly, diet plays 
an important role in the regulation of chronic inflammation (16) by altering blood 
inflammatory biomarkers (17). Chronic inflammation is considered a hallmark of the 
causation and progression of cancer (40).  
Epidemiological studies on the role of individual nutrients or food items on disease 
outcome are often inconclusive, which may in part be due to dietary interactions, 
multicollinearity (23, 24) and inability to detect small effects(25). Diet patterns are used 
commonly in epidemiological research to overcome some of the limitation associated 
with individual nutrient based studies. Diet patterns not only represent total diet or key 
factors in the diet (27)  and the frequency of its consumption but also reflect an 
individual’s food preferences modulated by the combination of genetic, cultural, social, 
health, environmental, behavioural and economic determinants (28).  
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Data-driven and hypothesis-driven are two major approaches that are used in literature to 
identifying diet patterns (29). The former solely reply on inter-correlations among the 
food items and latter allows the researcher to incorporate their professional knowledge 
and understanding. Cluster and factor analysis are outcomes independent empirical data-
driven/posterior techniques determining dietary behaviour in the study population while 
index/score-based are hypothesis-driven based on adherence to prior recommendations or 
guidelines (30). 
This study is designed to assess and compare different diet patterns identified while 
estimating the CRC patient’s survival using the Newfoundland Colorectal Cancer Cohort. 
Meanwhile, the study investigates the role of diet-mediated inflammation assesses by DII 
on the risk of CRC. Compared with other parts of Canada NL has largely maintained its 
traditional diet, a Western-style with the high proportion of red meat and less vegetables 
and fruits (54). Despite, several studies have suggested the possible connection between 
single food or nutrients and risk of CRC (54-56) in this population; overall impact of 
individual’s diet has not been adequately assessed. Comparison amongst the diet patterns 
identified by different techniques will help to better understand the disease-diet 
interaction.  
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Abstract 
Objective Chronic inflammation is implicated in causing cancer. Diet plays an important 
role in regulating chronic inflammation by altering circulating levels of inflammatory 
biomarkers. Effect of single food or nutrient on cancer often is inconclusive; perhaps due 
to dietary interactions and multicollinearity. The aim of this study was to determine the 
pre-diagnostic inflammatory potential of overall diet in relation to risk for colorectal 
cancer (CRC). 
Methods: In all, 547 patients with CRC from Newfoundland Familial Colorectal Cancer 
Registry and 685 controls from the general population were identified. Data on socio-
demographic, medical history, lifestyle, and a 169-item food frequency questionnaire 
were collected retrospectively from both groups. Energy-adjusted Dietary Inflammatory 
Index (DII) score was calculated and used as both categorical and continuous variables 
for analysis. Odds ratio (OR) was estimated using multivariable logistic regression after 
adjusting potential confounders. A linear test for trend was performed using the median 
value in each quartile. 
Results: Overall energy-adjusted mean DII score was −0.81 (range −5.19 to 6.93). Cases 
(−0.73 ± 1.5) had slightly higher DII scores than controls (−0.89 ± 1.6; P = 0.04). After 
adjusting the potential confounders, a statistically significant association was found 
between DII score and CRC risk. Using DII as a continuous variable ( [OR]continuous 1.10, 
95% confidence interval [CI] 1.01–1.20) and categorical variable (OR quartile 1 versus 4 1.65, 
95% CI 1.13–2.42; P trend = 0.02). 
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Conclusion: Our findings indicate that pro-inflammatory diets are associated with an 
increased risk for CRC in the Newfoundland population. 
Keywords: Colorectal Cancer, Dietary Inflammatory Index, Inflammation, Risk factors 
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Introduction 
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. 
It is the third most common cancer in men and second amongst women (188).  CRC vary 
widely with higher incidence rates in developed nations and lower rates in Asian, African, 
and many Latin American countries. (1)  CRC has become one of the major health 
problems in Canada, with an estimated 26,100 new cases and 9,308 deaths in 2016 (4). 
According to the Canadian Cancer Society, Newfoundland and Labrador (NL), the most 
eastern province, has the highest age-standardized incidence rate of CRC in Canada, at 96 
per 100,000 compared to the national average of 67 per 100,000 (4).  The high rates of the 
disease in NL can be explained, in part by a high prevalence of families with a 
predisposition to hereditary colon cancer (5). However, environmental factors that are an 
important component of CRC risk play a vital role in both the risk and progression of the 
disease (6-10).  
Genetic predisposition (5), age (12), and gender (13) are non-modifiable risk factors 
while physical inactivity, overweight/obesity, poor diet, excess alcohol consumption, and 
smoking are modifiable factors associated with risk of CRC (14, 189). Dietary behaviour 
is considered to be one of the important determinants of cancer (190). Diet plays an 
important role in the regulation of chronic inflammation (16) by altering levels of 
circulating inflammatory biomarkers (17). Inflammatory microenvironment involves the 
production of cytokines and chemokines leading to tumour initiation, growth, and 
invasion (18) by activating signalling pathways favouring carcinogenesis (19) and is 
particularly notable in CRC and other epithelial cancers (20).   
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Refined and processed foods, a typical Western diet pattern including high calorie drinks, 
soda, canned foods with heavy syrups, cheese, sugary and refined cereals, refined and 
processed meats, etc., have higher inflammatory potential (21) while a prudent diet 
pattern with higher intake of fruits and vegetables are anti-inflammatory in nature (22).   
Despite food, and nutrients including supplements that have been studied independently 
in relation to the risk and survival of CRC patients, little is known about the net 
inflammatory potential of overall diet on risk and survival of CRC patients as diet 
involves complex interactions of nutrients (23, 24).  Since foods/nutrients act together 
(191-194), any assessment of single food or nutrient is likely to be confounded (195, 
196). The Dietary Inflammatory Index (DII) assesses the overall dietary inflammatory 
potential of the diet based on the food/nutrient response to the six inflammatory 
biomarkers (IL-1β, IL-4, IL-6, IL-10, TNF-α, and C-reactive proteins.)(34). A higher DII 
score represents greater inflammatory potential.  The DII has been validated and used in 
different studies to assess the effect of dietary inflammation on the risk and survival of 
chronic diseases and cancers (197, 198). 
Compared with other parts of Canada, NL has largely maintained its traditional diet, a 
Western-style with the high proportion of red meat and the less vegetables and fruits 
(199).  While several studies have suggested the possible connection between food or 
nutrients and risk of CRC (199-201) in this population, the overall impact of diet has not 
been assessed.  This study aims to determine the pre-diagnostic inflammatory potential of 
an individual’s diet and its association with the risk of CRC in the NL population.  
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Material and Methods 
Study Population. This study utilized data from the previous population-based case-
control study from NL (199).  CRC cases were recruited using the Newfoundland 
Colorectal Cancer Registry (NFCCR) which was modelled on the Ontario Familial 
Colorectal Cancer Registry.  Histo-pathologically confirmed cases aged 20-74 years 
between 1999 and 2003 were included as cases. Incident CRC diagnosis was identified 
using codes from the International Classification of Diseases 9th revision. Controls were 
selected from the NL population through random-digit dialling using telephone numbers 
provided by Bell Aliant (a local telephone company in NL). Controls were age-matched 
with cases by 5-year strata. Both cases and controls were residents of NL at time of 
diagnosis or interview.  A total of 1,232 participants (547 cases and 685 controls) were 
included in the study. A detailed description of the selection of cases and controls is 
described elsewhere (199). Informed consents were obtained from all research 
participants, and the study was carried out with the approval by the Health Research 
Ethics Authority, Memorial University of Newfoundland, in accordance with the 
Declaration of Helsinki.  
Exposure variables. Information including personal history, lifestyle, and dietary 
characteristics was collected using a personal history questionnaire (PHQ) and a food 
frequency questionnaire (FFQ), which were developed as part of the larger study and 
were collected retrospectively one year prior to diagnosis or interview.  Briefly, the PHQ 
consisted of 74 questions including the history of bowel screening, medical conditions, 
use of medications, diet, physical activity, intake of alcohol, tobacco use, socio-
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demographic and economic information, and reproductive factors for females. Similarly, 
dietary intake data were collected using a 169-item FFQ similar to the Ontario FFQ 
customized to include foods from NL.  Nutrient content was calculated using the 
Canadian Nutrient File, 2005.  
Dietary inflammatory index score was calculated as described elsewhere (34). Briefly, an 
individual’s intake of food or nutrients was linked to a global database with mean and 
standard deviation consumption of up to 45 nutrient parameters.  For each subject and 
each food parameter, a z-score was derived.  These scores were converted to a centred 
percentile score to reduce the effective skewness and multiplied by the respective food 
parameter effect derived from the literature review and scoring of 1,943 articles.  All food 
parameter-specific DII scores were summed to determine an individual’s DII score. The 
DII score was adjusted for the energy (from macronutrients and alcohol) using the 
residual method for both male and female separately (202).  Ninety-five percentile data 
for energy was used for the analysis to remove the extreme values from both extremes of 
the distribution. 
A higher DII score represents the greater inflammatory potential of diet.  For the current 
study, 29 food parameters were available and used in computing the DII score. These 
included carbohydrate, protein, total fat, alcohol, onion, tea, tea (Herbal), pepper, β-
carotene, vitamin B-6, Vitamin B-12, caffeine, cholesterol, energy, fibre, folic acid, iron, 
monounsaturated fatty acid (MUFA), polyunsaturated fatty acid (PUFA), niacin, 
magnesium, riboflavin, saturated fatty acid, selenium, thiamine, vitamin-E, vitamin-D, 
vitamin C, and zinc. The Calculated DII scores were analysed categorically and as 
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continuous variables.  Quartiles were based on DII scores in controls, and the respective 
quartiles are Quartile I (<-2.036), Quartile II (-2.036 to <– 0.88), Quartile III (-0.88 to 
<0.358), and Quartile IV (≥0.3582). 
Adjustment variables. Potential confounding factors include age, sex, body mass index 
(BMI) (classified as < 25, 25-29.99, ≥30 kg/m2), physical activity measured (metabolic 
equivalent hours/week (METs/week classified as <10, 10-49.99, ≥50), medical history 
including cholesterol level, triglycerides, family history of CRC, polyps, diabetes, history 
of colon screening, cigarette smoking (classified as: Yes and No;  Yes  means smoke 
1cigarette/day for 3 months or more), and alcohol consumption (classified as: standard 
drink/week; not at all, <15 standard drink/week, and ≥15 standard drink/week), regular 
use of medications including non-steroidal anti-inflammatory drugs (NSAIDs), and 
reported hormone replacement therapy (HRT, females only). 
Theory/calculation. Statistical analyses were performed using SAS® statistical software 
(version 9.4 SAS Institute, Cary, NC, USA). The characteristics of cases and controls 
were compared by t-test and ANOVA for continuous variables and chi-square test for 
categorical variables.  
Baseline characteristics were examined across the quartiles of DII. Odds ratio and 95% 
Confidence Interval (OR; 95% CI) were estimated using multivariable logistic regression 
model adjusting for age in the crude model and age of diagnosis, sex, smoking, history of 
screening, diabetes, high cholesterol, polyps, and physical activity in the final model. The 
basis for assessing the role of potential confounding factors included: (1) existing 
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evidence, (2) biological plausibility, (3) whether the regression coefficient of the primary 
dependent variable changed by 10% or more after addition of the potentially confounding 
variable, or (4) whether the covariate entered the model at P<0.10. A stepwise selection 
procedure was used to identify potential confounding factors. 
 OR for continuous variables were calculated using DII score as a continuous variable. A 
linear test for trend was performed using the median value in each quartile. All tests of 
statistical inference employed a two-sided alpha level of 0.05. 
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Results 
Characteristics of Study Subjects 
Table 1 Comparison between cases and controls across the baseline characteristics 
(univariate analysis), Newfoundland and Labrador Case-Control Study, 1999-2003. 
Baseline Characteristics Cases Controls P-value 
Subjects 547 (44.40) 685 (55.60)  
Age a 62.52±9.06 60.53±9.52 <0.001 
Energy-adjusted DII -0.73±1.5 -0.89±1.6 0.04 
Sex  
Male 329 (60.15) 405 (59.12) 0.71 
 Female 218 (39.85) 280 (40.88) 
Co-Morbidity: cholesterol c  (n=1223) 
High 166(30.51) 252 (37.11) 0.01 
Normal 378 (69.49) 427 (62.89) 
Co-Morbidity: Triglyceride  c  (n=1189) 
High 60 (11.41) 68 (10.26) 0.52 
Normal 466 (88.59) 595 (89.74) 
Co-Morbidity: Diabetes c   (n=1223) 
Yes 119 (21.76) 89 (13.17) 0.001 
No 428(78.24) 587 (86.83) 
Smoking c   (n=1232) 
  Yes 402 (73.49) 429(62.63)  
0.001    No 145 (26.51) 256 (37.37) 
Alcohol: Standard drink/week  (n=1186) 
  No 213 (41.04) 275 (41.22)  
0.98 
 
  0-14.99 251 (48.36) 320 (47.97) 
  ≥15 55 (10.60) 72 (10.79) 
Body Mass Index  (kg/m2) (n=1202) 
  <25 150 (28.20) 211 (31.49)  
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  25-29.99 227 (42.67) 314 (46.86) 0.01 
  ≥30 155 (29.14) 145 (21.64) 
Regular use of NSAIDs (n=1229) 
  Yes 181(33.15) 263 (38.51)  
0.05   No 365 (66.85) 420 (61.49) 
Use of Hormonal Contraceptives (N=452) 
  Yes 98 (44.95) 115 (56.57)  
<0.001   No 120 (55.05) 119 (43.43) 
Family History of CRC c  (n=1232) 
  Yes 16 (2.93) 9 (1.31) 0.06 
  No 531 (97.07) 676 (98.69) 
Physical Activity (Met-hrs./week) (n=1160) 
  ≤10 (Low) 117 (32.42) 190 (28.19)  
0.002   10-49.99 (Med) 167 (30.59) 270 (40.06) 
  ≥ 50 (High) 202 (37.00) 214 (31.75) 
Total Energy Intake (Kcal/day) a 
 2518.3±1066 2305.6±908.4 0.001 
Any screening (n=1258) 
  Yes 71 (12.97) 146 (21.31) 0.001 
  No 476 (87.03) 565 (78.69) 
History of Polyp (n=1202) 
  Yes 263 (49.07) 85(12.76) 0.001 
  No 273 (50.93) 581 (87.24) 
 
a Continuous variables were presented as mean ±SD 
b Categorical variables were presented as numbers (%). Association between baseline 
variables and subjects were assessed based on Chi-square.  
c Fisher’s Chi-square test 
Column total varies due to the missing values 
 
Table 1 shows the characteristic of cases and controls. Mean self-reported blood 
cholesterol level amongst the controls was higher than the cases. Cases were more likely 
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to be diabetic, obese, and smokers than controls.  Hormonal contraceptive use 
significantly differed between cases and controls.  Total calorie intake for the cases was 
higher than the controls. Calorie-adjusted mean DII score was -0.81 (SD= ±1.57; Range: -
5.19 to 6.93). Cases (-0.73±1.5) had slightly higher DII score than controls (-0.89±1.6) 
(p=0.04).  There was no statistically significant association between sex, triglyceride 
status, alcohol intake, use of anti-inflammatory drugs, or history of CRC between cases 
and controls.  
Table 2 shows characteristics of the study population across energy-adjusted quartiles of 
the DII.  Younger participants were likely to consume more pro-inflammatory diets. 
Those who were diagnosed with CRC at younger ages had diets with higher inflammatory 
potential than those who were diagnosed at older ages.  Men and smokers were observed 
to consume more pro-inflammatory diets. There was no significant association between 
family history of cancer, history of screening, polyps, use of hormonal contraceptives, use 
of alcohol, diabetes status, high cholesterol, higher BMI, and self-reported diet.  
Table 2: Characteristics of study population across energy-adjusted quartiles of DII 
(univariate analysis), Newfoundland and Labrador Case-Control Study, 1999-2003. 
 
Characteristics 
Mean ±SD/% 
Energy Adjusted Dietary Inflammatory Index (Quartiles) 
Quartile 1 
(N=308)   
  
Quartile 2 
(N=309) 
Quartile 3 
(N=309)       
Quartile 4 
(N=306) 
P 
value 
Current Age a 63.38±8.08 62.11±8.99 60.86±9.4 59.24±10.34 <0.001 
Diagnosis age a 
(For cases only) 
63.13±7.92 61.64±7.96 60.09±9.02 57.23±9.95 0.001 
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Sex  
  Male 149 (48.38) 174 (56.31) 203 (65.70) 208 (67.97) 0.001 
  Female 159 (51.62) 135 (43.69) 106 (34.30) 98 (32.03) 
Diagnosis Age/ Interview (n=1231)  
  18-49 15 (4.87) 31 (10.03) 38 (12.30) 60 (19.67)  
0.001   50-59 87 (28.25) 94 (30.42) 101 (32.69) 88 (28.85) 
  60+ 206 (66.88) 184 (59.55) 170 (55.01) 157 (51.48) 
Body Mass Index (kg/m2) (n=1202) 
  <25 102 (33.44) 90 (30.00)  83 (27.48) 86 (29.15)  
0.273   25-29.99 143 (46.89) 133 (44.33) 139 (46.03) 126 (42.71) 
  ≥30 60 (19.67) 77 (25.67) 80 (26.49) 83 (28.14) 
Level of Physical activity Mets/week (n=1215) 
  <10 (Low) 64 (22.62) 98 (31.92) 97 (31.80) 103 (33.99) 0.0018 
10-49.99 (Med) 136 (44.59) 102 (33.23) 91 (29.84) 108 (35.64) 
  ≥50 (High) 100 (32.79) 107 (34.85) 117 (38.36) 92 (30.36) 
Smoking (n=1232) 
Yes 187 (60.71) 199 (64.40) 214 (69.26) 231 (75.49) 0.007 
 No 121 (39.29) 110 (35.60) 95 (30.74) 75 (24.51) 
Alcohol (Standard drink/week) (n=1186) 
  No 136 (44.74) 121 (41.72) 122 (40.40) 109 (37.59)  
  0-14.99 146 (48.03) 140 (48.28) 146 (48.34) 139 (47.93) 0.15 
 ≥ 15 22 (7.24) 29 (10.00) 34 (11.26) 42 (14.48) 
Co-Morbidity: Diabetes (n=1223) 
  Yes 62 (20.33) 55 (18.03) 53 (17.15) 38 (12.50) 0.07 
  No 243 (79.67) 250 (81.97) 256 (82.85) 266 (87.50) 
Co-Morbidity: High Cholesterol Status (n=1223) 
  Yes 116 (37.78) 100 (33.00) 108 (35.18) 94 (30.72) 0.29 
  No 191 (62.21) 203 (67.00) 199 (64.82) 212 (69.28) 
Co-Morbidity: High Triglyceride  (n=1189) 
  Yes 40 (13.56) 38 (12.71) 26 (8.72) 24 (8.08) 0.06 
  No 255 (86.44) 261 (87.29) 272 (91.28) 273 (91.92) 
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a Continuous variables were presented as mean ± SD. 
Test/ANOVA and Chi-square tests are used for the continuous and categorical variables, 
respectively 
 
 
 
 
 
 
 
 
 
 
Co-Morbidity: History of Polyp (n=1202) 
  Yes 88 (28.66) 91 (30.43) 84 (28.47) 85 (28.24)  
0.93   No 219 (71.33) 208 (69.57) 211 (71.53) 216 (71.76) 
Use of Non-steroidal Anti-Inflammatory Drugs (n=1229) 
  Yes 124 (40.26) 109 (35.39) 120 (38.83) 91 (29.93) 0.03 
  No 184 (59.74) 199 (64.61) 189 (61.17) 213 (70.07) 
Family History of CRC (n=1232) 
  Yes 10 (3.25) 4 (1.29) 2 (0.65) 9 (2.94) 0.06 
  No 298 (96.75) 305 (98.71) 307 (99.35) 297 (97.06) 
Screening (n=1232) 
  Yes 63 (20.45) 64 (20.71) 45 (14.56) 45 (14.71) 0.05 
  No 245 (79.55) 245 (79.29) 264 (85.44) 261 (85.29) 
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Table 3 OR of CRC for energy-adjusted DII amongst cases and controls 
(multivariable-adjusted analysis), Newfoundland and Labrador Case-Control 
Study, 1999-2003. 
 
 
Quartile1  
 (N=308) 
Quartile 2 
(N=309) 
Quartile 3 
(N=309) 
Quartile 4  
(N=306) 
P  
trend 
ORa 
Case 117 150 135 145   
Control 191 159 174 161   
Crude OR 1# 1.54  
(1.18-2.12) 
1.267 
(0.91-1.74) 
1.46  
(1.05-2.01) 
0.040 1.05 
(0.98-1.14) 
Age-adjusted 
OR 
1# 1.59 
(1.15-2.20) 
1.35  
(0.98-1.87) 
1.64 
 (1.18-2.27) 
0.011 
 
1.09 
(1.01-1.17) 
Multivariate 
OR** 
1# 1.61 
(1.1-2.34) 
1.29  
0.89-1.89) 
1.65 (1.13-
2.42) 
0.03 1.10 
(1.01-1.20) 
	
# Reference category                                                   
** Adjusted for age, sex, diabetes, cholesterol, smoking, alcohol intake, physical activity, 
screening history, and use of inflammatory drugs                                               
 a Odds Ratio (OR) for the continuous variable 
Figures in parenthesis shows the 95 % confidence intervals  
	
Crude and adjusted OR is shown in Table 3. In crude analysis, there was a significant 
association between DII quartiles and risk of colorectal cancer (OR quartile 1 vs. 4 1.46 95% 
CI 1.05-2.01; p- trend =0.045). The relation was not significant while using DII as a 
continuous variable (OR continuous 1.05, 95% CI 0.984, 1.135). In age-adjusted model, a 
positive association was seen between DII and CRC (OR continuous 1.09, 95% CI 1.01, 1.17) 
and (OR quartile 1 vs. 4 1.64, 95% CI 1.18, 2.27; p-trend =0.01).  Similarly, in the 
multivariable model after adjusting for the potential confounders, significant associations 
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were observed between DII score and risk of CRC (OR continuous 1.10, 95% CI 1.01, 1.20) 
and (OR quartile 1vs 4, 1.65, 95% CI 1.13 - 2.42), (p-trend = 0.03).   
 
Discussion  
In this study, we compared the DII score in cases and controls as both a categorical and a 
continuous variable. The results showed increased CRC risk with a pro-inflammatory 
diet.  
Previous studies on the same NL population have reported the increased risk of CRC with 
pickled red meat (199), total energy intake (36), and an inverse association with vitamin 
D and calcium (203).  Similarly, other epidemiological studies have revealed an 
association between CRC and higher dietary cholesterol and total saturated fat (204). In 
contrast, increased consumption of total fibre (205), PUFA (206), and micronutrients and 
spices (turmeric, cloves, ginger, fennel, kokum, fenugreek, and black cumin) are seen to 
be protective against CRC (112). However, these study findings are limited to these 
foods, and nutrients are consumed together with other food items and nutrients, and thus 
the dietary interactions may confound the associations (195, 196).   
A normal human diet consists of foods with both pro-inflammatory and anti-
inflammatory properties (207).  The DII score measures the overall functional aspects of 
food and nutrients on the basis of inflammatory potential (34). Epidemiological studies 
have shown the positive association between DII score and circulating levels of 
inflammatory markers (208), suggesting the effectiveness of the use of DII in assessing 
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the risk of chronic diseases including cancers. One of the possible mechanisms for the 
diet causing CRC is through the increasing level of (C- Reactive Proteins) CRP and 
adhesions molecules (209). These molecules lead to an increase in insulin resistance 
(210), which is associated with CRC. Similarly, inflammatory microenvironment involves 
the production of cytokines (interleukins, tumour necrosis factors, etc.) and chemokines 
leading to tumour initiation, growth, and invasion (18) by activating signalling pathways 
favouring carcinogenesis (19). 
Findings from this study are in line with previous studies.  Mean DII in the current study was -
0.81 (SD±1.57), which is similar to the levels observed in the Iowa Women’s Health Study; i.e., -
0.87 (SD ±2.02) (211). The current study showed an almost 60% increase in CRC risk 
comparing the highest DII quartile to reference quartile after adjusting for potential 
confounders.  This increase is much higher than what was observed in either the Iowa 
Women’s Health Study (20%) (211) or the Women’s Health Initiative (35% ) (212). 
Higher risk in this population might be due to its unique diet pattern, which is 
characterized by high consumption of pickled and red meats and low intake of fruits and 
vegetables(199). Similarly, higher risk associated with more of inflammatory diet was 
seen for CRC in the Bellvitge Colorectal Cancer Case-Control Study (213).  The DII has 
been associated with the risk of other cancers. For example, the risk of prostate cancer is 
seen to be associated with a higher DII score in a Jamaican study (214).  In an Italian 
Case-Control study, the DII was associated with an increased risk of laryngeal cancer 
(215). 
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No other variable (age groups, body mass index, history of polyps, co-morbidities 
including diabetes, high cholesterol, sex, physical activity, location by the anatomical 
sites, or use of anti-inflammatory drugs) was found to significantly modify the association 
between DII score and risk of the CRC (all P -for interaction >0.05). Statistically, 
significant effect modification has been inconsistent across studies (212, 216) suggesting 
the complexity of environmental factors with the risk of CRC. An earlier study in NL 
suggested that the higher incidence of CRC attributed to genetic factors, which might be 
distributed more or less equally in both cases and controls; NL is seen to have a unique 
founder population effect	(5).  
This study has some limitations. Recall bias may distort results because the dietary recall 
was directed towards intake one year prior to diagnosis or the date of interview. However, 
there is evidence to suggest that diet pattern tends to remain relatively stable over time 
(217). The dietary supplement can also modify the inflammatory potential of diet. 
However, in this study dietary supplementation was not considered which might have 
underestimated the intake of some nutrients. The results from the current study are limited 
to a population of primarily European origin as they were more than 95% of the study 
population. It should be noted that polymorphisms of inflammatory genes may affect 
levels of circulating inflammatory biomarkers and, therefore, influences the association 
with CRC (218). Similarly, while classifying the study population based on the BMI all 
individuals with BMI below 25kg/m2 were included in the same group as the percentage 
of individual below 18.5kg/m2 was minimal.  
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Conclusion 
In conclusion, pro-inflammatory diets appear to be associated with increased risk of CRC 
in NL population suggesting dietary-mediated inflammation plays an important role in 
colon carcinogenesis. 
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Abstract 
Background Diet patterns are used commonly in epidemiological research, yet there 
have been few studies assessing if and how research results may vary across diet patterns. 
This study aimed to estimate survival outcomes using different diet patterns and compare 
amongst the diet patterns in the Newfoundland and Labrador Colorectal Cancer cohort.   
Methods Data-driven diet pattern (Cluster Analysis (CA), Principal Component Analysis 
(PCA)) and hypothesis-driven pattern (Alternate Mediterranean Diet (Alt-Med), 
Recommended Food (RFS), Dietary Inflammatory Index (DII) scores) were identified 
using 169-item food frequency questionnaire. A total of 532 cases diagnosed between 
1999 and 2003 were followed until 2010. Overall survival (OS) and Disease-Free 
Survival (DFS) time were calculated. Comparisons were made with adjusted Cox 
proportional Hazards Ratios (HRs), correlation coefficients and the distributions of 
individuals in defined clusters by quartiles of factor and index scores. 
Results A total of 170 cases died from any cause and 29 had a cancer 
recurrence/metastasis during follow-up. Processed meats as classified by PCA (HR 1.82; 
95% confidence interval (CI) 1.07-3.09), clusters characterized by meat and dairy 
products (HR 2.19; 95% CI 1.03-4.67) and total grains, sugar, soft drinks (HR 1.95; 95% 
CI 1.13-3.37) were associated with poor DFS.  Poor adherence to Alt-Med was associated 
with higher risk of all-cause mortality (HR 1.62; 95% CI 1.04-2.56).  Prudent vegetable, 
high sugar pattern, RFS and DII had no significant association with both OS and DFS.    
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Conclusion Survival outcome estimation varied across the diet pattern which is attributed 
to the differences in the foundation of each pattern.  
Keywords:    Colorectal Cancer - Diet patterns - Factor analysis - Cluster analysis - Index 
analysis  
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Background 
Diet and behavioural factors have crucial roles in the risk and progression of several 
chronic diseases including colorectal cancer (CRC) (15). Epidemiological studies on the 
role of a single nutrient or food items on disease outcome are often inconclusive, which 
may in part be due to dietary interactions, multicollinearity (23, 24) and/or inability to 
detect small effects (25). Diet patterns are advantageous in nutritional epidemiology to 
explore the combined effects of total diet on health and to some extent overcome these 
limitations (26). Diet patterns not only represent total diet or key factors of diet (27) and 
the frequency by which foods are habitually consumed, but also reflect an individual’s 
food preferences modulated by a combination of genetic, cultural, social, health, 
environmental, behavioural and economic determinants (28).  
Data-driven and hypothesis-driven are two major approaches to identify diet patterns 
(29). Cluster and factor analysis are outcome independent empirical data-driven 
techniques determining dietary behaviour in the study population while index/score-based 
are hypothesis-driven based on adherence to prior recommendations or guidelines (30). 
Studies on how outcome estimation may vary across these different patterns are limited 
and comparing across the patterns is recommended to better understand disease diet 
association (35). However, such studies are limited. This study aimed to investigate and 
compare the relation between various pre-diagnostic diet patterns and risk of mortality in 
CRC patients using the Newfoundland and Labrador Familial Colorectal Cancer cohort.  
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Briefly, cluster analysis (CA) divides individuals into mutually exclusive, non-
overlapping groups based on mean dietary intakes (gm) (182). Food intake common to all 
contributes less to cluster formation. Optimal clusters formed by the maximum ratio of 
variance across the cluster to within the cluster. No gradient is formed hence comparison 
is done with the reference cluster. Factorial analysis, specifically Principal Component 
Analysis (PCA), an exploratory approach, reduces a large set of correlated variables to 
smaller sets of non-correlated variables, which captures the majority of dietary variations 
within the study population. Linear combinations are created and each individual receives 
a score called factors (31). A higher score represents higher adherence to the particular 
diet pattern.  
Recommended food score (RFS) (32) and alternate Mediterranean diet score (Alt-Med) 
(33) are commonly used index-based diet patterns for which scoring is based on 
adherence to US dietary guidelines and the Mediterranean diet, respectively. The  Dietary 
Inflammatory Index score (DII) (34) is based on each nutrient response to six 
inflammatory biomarkers which leads to dietary intake being classified as pro-
inflammatory vs. anti-inflammatory. For such indexes, patterns were derived from 
gradients, which are then compared by referring to reference quartiles.  
Methods and Materials 
Study population 
This study used data from the Newfoundland Familial Colorectal Cancer Registry 
(NFCCR). Five hundred and thirty-two pathologically confirmed CRC patients diagnosed 
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between 1999 and 2003 and aged 20-75 years were included in the study. A detailed 
description of the study population is published elsewhere (219). Briefly, CRC cases 
followed from the date of diagnosis until April 30th, 2010. Overall survival (OS; the time 
between the dates of diagnosis to the date of death from all causes until end of follow up 
period) and Disease-free survival (DFS; the time between the dates of diagnosis to the 
date of death, recurrence, or metastasis (whichever came first) was calculated.  
Study outcomes were obtained using follow-up questionnaires, local newspapers (e.g., 
death notices), death certificates, autopsy, pathology, radiology, surgical reports, as well 
as physician's notes. Additional data gathered from the Dr H. Bliss Murphy Cancer Care 
Foundation and Statistics Canada (220). As cause-specific death was not available for all 
deceased participants, all-cause mortality used for analysis. Patients without the event of 
interest were censored at the date of the last contact.  
Data collection tools 
Participants completing the consent were asked to complete validated food frequency 
questionnaire (FFQ) (221), personal history questionnaire (PHQ) and some further 
questions pertaining to family history and medical history. Briefly, the PHQ consisted of 
74 questions including the history of bowel screening, medical conditions, use of 
medications, physical activity, intake of alcohol, tobacco use, socio-demographic 
information, and reproductive factors for females. Similarly, dietary intake data were 
collected using a 169-item FFQ retrospectively a year before the diagnosis.  Nutrient 
content calculated using the Canadian Nutrient File, 2005.  
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MSI (Microsatellite instability) and BRAF  have been associated with cancer prognosis 
and survival (222, 223).  P V600E BRAF mutation and MSI for the tumour DNA have 
been determined in a previous study using standard protocol(224). MSI status was 
defined as MS high if 30% or more of the markers were unstable and MS-stable/MS-low 
if less than 30% showed instability (225). 
Identifying diet patterns 
For CA, 169 food items were classified into 39 different food groups depending on the 
ways they are taken (cooked, raw, drinks, etc.) and nutrient profile. Food groupings are 
attached in Appendix 1. Clusters were identified by using K-means non-hierarchical 
method, an iterative technique which groups data into k clusters in such a way as to 
maximize the R2 (R2 = 1 − W/T), where W is the sum of squared Euclidean distances 
between each data point and its within-cluster mean, and T is the sum of squared 
distances between each data point and the overall mean.  FASTCLUS procedure in SAS 
was applied. Clusters with less than 5 participants were temporarily removed while 
forming the stable cluster. A detailed description of cluster formation is described 
elsewhere (225). Overall, four stable clusters were identified. Characteristics of clusters 
are given in appendix 2.  
Three patterns were identified using the PCA. Briefly, exploratory principal component 
factor analysis was conducted using the same 39 predefined food groups. A varimax 
rotation (orthogonal) was applied to identify uncorrelated food groups. Factor Eigen value 
greater than 1.15, the scree plot and proportion of variance explained were used to 
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identify the number of factors. Patterns were labelled based on factor loading ≥ 0.5. The 
factor score of each participant was obtained by summing the intake of each food group 
multiplied by optimal weights and divided into quartiles. A higher factor score represents 
greater adherence to that particular diet pattern. Factor loading and explained variances 
for three major diet patterns are shown in appendix 3.  
The RFS method developed by Kent, et.al (32) is based on fruits, vegetables, whole 
grains, lean meats or meat alternatives, and low-fat dairy products. Each individual is 
given 1 point for each recommended food consumed at least weekly. Based on FFQ, the 
maximum score is 47. Total RFS score varies with the number of food items in the FFQ 
(227).  A higher score represents better adherence to RFS.  Details are attached in 
Appendix 4. 
The Alt-Med score is based on the Mediterranean diet scale (228); scoring is based on 9 
food groups. If the intake (servings/day) of a particular food group is greater than the 
median, then it is scored one (versus zero). For red and processed meat, reverse scoring is 
done. For alcohol, if intake is between 5-25 g/d, then it is scored as 1 (versus zero). The 
maximum Alt-Med score is 9 with a higher score representing better adherence to the Alt-
Med diet. Details of the food groups are attached in Appendix 5. 
Detailed descriptions of the DII score are provided elsewhere (34, 187). Briefly, a total of 
29 nutrient parameters were scored based on their inflammatory response to 6 
inflammatory biomarkers; IL-1β, IL-4, IL-6, IL-10, CRP and tumour necrosis factor 
(TNF-α). These included carbohydrate, protein, total fat, alcohol, onion, tea, tea (herbal), 
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pepper, β-carotene, Vitamin B-6, Vitamin B-12, caffeine, cholesterol, energy, fibre, folic 
acid, iron, monounsaturated fatty acid (MUFA), polyunsaturated fatty acid (PUFA), 
niacin, magnesium, riboflavin, saturated fatty acid, selenium, thiamine, Vitamin-E, 
Vitamin-D, Vitamin-C and zinc. A higher score represents the higher inflammatory 
potential of the diet. All index-based scores are categorized into quartiles for analysis. 
Statistical analysis 
Adjusted hazards ratios were estimated using Cox proportional hazard analysis using SAS 
version 9.4 (SAS Institute, Inc. Cary). Comparisons across patterns were made with 
adjusted HRs, correlation coefficients and distributions of individuals in clusters by 
quartile of factor and index scores. Potential confounding factors include age; sex; body 
mass index (BMI) (classified as < 25, 25-29.99, ≥30 kg/m2);  physical activity (metabolic 
equivalent hours/week, METs/week,  classified as <10, 10-50, ≥50);  medical history 
including cholesterol level; triglycerides; family history of CRC; polyps; diabetes;  
history of  screening; smoking (classified: Yes and No; Yes means smoke at least 1 
cigarette/day for 3 months or more); alcohol consumption (classified: standard 
drink/week; not at all, <15 and ≥15); and regular medication usage including non-
steroidal anti-inflammatory drugs (NSAID) and reported hormone replacement therapy 
(HRT, females only). Energy adjustment was done using the residual method wherever 
applicable (229). 
The basis for assessing potential confounding factors included: existing evidence, 
biological plausibility, whether the regression coefficient of the primary variable of 
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interest changed by 10% or more after addition of the potentially confounding variable 
for every covariate entered model at P<0.10. A stepwise selection procedure used to 
identify potential confounding factors. 
Results 
Characteristics of study population  
Mean age of participants and mean age at diagnosis was 62.53±9.06 years and 
60.42±9.02 years, respectively. A total of 170 cases died from all causes and 29 had a 
cancer recurrence or metastasis at the end of the follow-up. Median Overall survival (OS) 
time was 6.42 years (Range: 1.34-10.88 years). Almost 68% of the participants were 
censored for OS and 62.6% for DFS during analysis.  
Table 4 Characteristics of study participants with their overall survival status 
(Univariate); Newfoundland and Labrador Familial Colorectal Cancer Cohort (1999-
2003) 
 
Characteristic No. of patients*  No. of deaths (%) P log-rank 
Age at diagnosis     
≤60 231 62 (26.83)  
>60 301 108 (35.88) 0.04 
Sex    
    Female 211 57 (27.02)  
    Male 321 113 (35.20) 0.02 
Family history    
   Yes 16 6  (37.5)  
    No 516 164 (31.78) 0.61 
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Reported screening procedure     
   Yes 68 15 (22.05)  
   No 464 155 (33.4) 0.08 
Stage at diagnosis    
   I/II 311 74 (23.79)  
   III/IV 221 96 (43.43) <0.001 
Diabetes History    
Yes 115 42 (36.52) 0.22 
No 417 128 (30.69) 
History of High Cholesterol 
   Yes 153 44 (28.75)  
   No 349 117 (33.52) 0.44 
Tumour location    
Colon 349 105 (30.09)  
    Rectum 183 65 (35.51) 0.25 
Smoke    
Never 139 34 (24.44)  
0.07     Yes  393 136 (34.60) 
Physical Activity  (Met-hrs/week)    
     Low  (<10) 175 52 (29.71)  
     Median (10-50) 163 56 (34.35) 0.27 
     High (50+) 193 62 (32.12)  
MSI status    
    MSI-L 440 154 (35.0)  
    MSI-H 61 6 (9.83) <0.002 
Reported chemo Therapy    
   Yes 108 42 (38.88)  
   No 421  128 (30.40) 0.06 
 
MSI, Microsatellite instability; MSI-L, Microsatellite instability low; MSI-H 
Microsatellite instability High * Column total varies due to missing values. 
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Table 4 presents the characteristics of the study population with the log-rank test. In the 
univariate test, there is a significant difference in the OS across the age groups, gender, 
diagnosis stage and microsatellite instability status. A family history of CRC, reported 
screening status, history of co-morbidity including diabetes, higher blood cholesterol 
level, the location of a tumour, smoking status, physical activity and reported 
chemotherapy had no significant association with the survival. 
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Diet patterns and survival outcome estimation 
Table 5  Diet patterns and Colorectal Cancer Survival (Multivariable adjusted analysis); 
Newfoundland and Labrador Familial Colorectal Cancer Cohort (1999-2003) 
Diet Pattern Identified by Disease-free Survival Overall Survival 
HR* (95% CI) P-trend HR (95% CI) p-trend 
Factor Analysis  
Processed Meat pattern* 1.82 (1.07 -3.09) 0.09 1.53 (0.85-2.27) 0.25 
Prudent Vegetable Pattern* 1.12 (0.69-1.84) 0.62 1.03 (0.61-1.75) 0.90 
High-sugar Pattern* 1.02 (0.62-1.69) 0.89 1.27 (0.72-2.23) 0.62 
Cluster Analysis     
Fruit and Veg, Whole Grain, 
Fish, wine (Cluster I) 
1#  1#  
Meat, dairy products(Cluster 
II),  
2.19 (1.03-4.67)  2.04 (0.96-4.35)  
Refined grains, sugar soft 
Drinks (Cluster III) 
1.95 (1.13-3.37)  2.05  (1.18-
3.57) 
 
Many foods  (Cluster IV) 1.55 (0.92-2.61)  1.50 (0.9-2.56)  
Index Based 
DII* 0.89 (0.56-1.42) 0.46 0.78 (0.47-1.25) 0.33 
Alt. Mediterranean Diet 
Score** 
1.44 (0.92-2.25) 0.08 1.62 (1.04-2.56) 0.03 
Recommended Food 
Score** 
1.51(0.92-2.48) 0.06 1.54(0.92-2.56) 0.045 
 
*Hazards Ratio while comparing with the highest quartile to the lowest (reference 
quartile)  
** Hazards Ratio while comparing with the lowest quartile to highest (reference quartile) 
# Reference group 
HR ratios Adjusted for energy, stage of cancer, sex, age, marital status, tumour location, 
screening history, intake of alcohol, radiation and chemotherapy status, Microsatellite 
instability status wherever applicable 
Events are defined as all-cause deaths for overall survival and death/recurrence/metastasis 
(which occurred earliest) for disease-free survival; 
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Table 5 shows the estimated adjusted hazards ratio corresponding to different diet 
patterns with 95% confidence interval.  Survival estimation varies with the diet pattern. 
Four different clusters were identified.  When compared with the reference cluster 
characterized by higher intake of fruits, vegetables, whole grains and wine (Cluster I), the 
cluster characterized by high intake of meat and dairy products (Cluster II) had significant 
worse DFS outcome (HR 2.19, 95% 1.03-4.67). The cluster characterized by a higher 
intake of refined grains, and sugar/soft drinks (Cluster III) had both poor  DFS  (HR 1.95,  
95%  1.13-3.37)and OS (HR 2.05,  95%  1.18-3.57) outcomes. The cluster characterized 
by the many food groups (Cluster IV) had no significant relation with either OS or DFS. 
This cluster that was based on many foods (cluster IV). No any specific distinguishing or 
dominating food item could be identified.  
Three diet patterns were identified using PCA: processed meat pattern, prudent vegetable 
pattern and high sugar pattern. Though the overall trend was not significant (p=0.09), the 
highest quartile of processed meat pattern significantly worse DFS (HR 1.82, 95% CI 
1.07-3.09), however, there was no significant association with OS. Neither the prudent 
vegetable pattern nor the high sugar pattern showed a significant outcome with both DFS 
and OS.  
While using index-based patterns, DII and RFS showed no significant association with 
either OS or DFS outcomes. The lowest quartile of the Alt-Med score was significantly 
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associated with the worse OS outcome (HR 1.62, 95% 1.04-2.56) but had no significant 
association with the DFS outcome. 
Comparison amongst the diet patterns 
Table 6 Spearman’s Correlation coefficients amongst the index-based scores obtained 
from FFQ; Newfoundland and Labrador Familial Colorectal Cancer Cohort (1999-2003) 
 RFS DII AltMED Score 
RFS 1 -0.61** 
<0.001 
0.60** 
<0.001 
DII  1 -0.61** 
<0.001 
Alt-Med   1 
DII, Dietary inflammatory Index; Alt-Med Diet, Alternate Mediterranean diet; RFS, 
Recommended Food Score        ** Significant at 0.05. 
 
Correlation coefficients amongst the index-based scores are described in table 6. 
Correlations were high and significant because of the similarity in the food items in 
scoring. A significant positive correlation was observed between RFS and the Alt-Med 
score (0.60; p=0.001). Significant negative correlations were found between the DII score 
and the Alt-Med (-0.601; p= 0.001) and RFS (-0.602; p=0.001) scores. 
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Table 7  Percentage of individuals in each cluster in highest/lowest quartile of 
factor/index score; Newfoundland and Labrador Familial Colorectal Cancer Cohort 
(1999-2003) 
 Cluster I Cluster II  Cluster III Cluster IV 
Characteristics 
of Cluster 
Fruits and Veg, 
whole grain, 
fish, wine 
Meat, Dairy 
products, mixed 
dishes 
Sugar/ drinks, 
total cereals 
and grains 
(refined 
included) 
Many foods 
Principle Component Analysis ** 
Processed Meat 
pattern 
15.29 91.89 38.38 16.21 
Prudent 
vegetable 
pattern 
58.60 24.32 6.06 11.46 
High Sugar 
pattern 
17.20 10.81 16.16 35.18 
Index based  
DII * 64.97 13.51 10.1 7.91 
AltMed Diet ** 36.31 8.11 6.06 9.88 
RFS ** 57.32 35.14 13.13 11.86 
 DII, Dietary inflammatory Index; AltMed Diet, Alternate Mediterranean diet; RFS, 
Recommended Food Score   ** Highest Quartile (reference)   * Lowest Quartile 
(reference) 
Table 7 examines the percentage of individuals in the highest quartile of factor and index 
score in different cluster describing some level of similarity in the foundation of scale. 
Almost 92% of individuals from the processed meat pattern were in Cluster II 
characterized by meat and dairy products.  Approx. 59% of individuals from highest 
quartile of the prudent vegetable pattern were in Cluster I characterized by fruits and 
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vegetables, whole grain, fish and wine.  Around 35% of individuals in the highest quartile 
of high sugar pattern were in the many foods group. In all three index-based patterns, 
lowest quartile of DII and highest quartile of Alt-Med and RFS showed the higher 
proportion of individuals from Cluster I characterized by fruits and vegetables, whole 
grain, fish and wine (64.97%, 36.31% and 57.32% respectively).  
Discussions 
Both data-driven and hypothesis-driven diet patterns were determined and relation with 
colorectal cancer patient’s survival was estimated. The hypothesis-driven pattern showed 
how study population is adherent to dietary recommendation while data-driven pattern 
explains how whole population dietary practice can be classified into different categories. 
As each diet pattern was designed to answer the different question, the discrepancy in the 
outcome estimation was expected despite some level of similarity in the foundation of 
diet patterns.  
In current study as identified by CA, the meat and dairy product cluster was associated 
with poor DFS while the refined grains, sugar, soft drinks cluster were associated with 
both poor DFS and OS. A processed meat pattern as identified by PCA was associated 
with poor DFS. Low adherence to the Mediterranean diet was associated with the poor 
OS. RFS and DII had no significant association with the survival outcomes. The 
magnitude of estimated HR also varied accordingly.  
Epidemiological studies reveal inconsistent results while assessing the relation between 
diet patterns and disease outcome in the same population, which is in line with the current 
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study. A study by Reedy J; et.al (35) showed that among males diet patterns and clusters 
characterized by fruits, vegetables, lower fats foods, an adherence to RFS and MED diet 
were associated with reduced risk of CRC. Among females, results were inconsistent; 
meat and potatoes pattern was associated with increased risk but neither MED nor RFS 
had a significant association. 
 In the Nurse’s Health Study (230) index-based score, AHEI (Alternate Healthy Eating 
Index) was associated with lower levels of free oestradiol while no association was found 
with the patterns identified by factor analysis. In the Health Professionals Follow-up 
Study cohort, the risk of incident fatal or nonfatal myocardial infarction and stroke (CVD) 
in the highest quintile of the HEI, alternate HEI, and RFS, respectively, were 28%, 39%, 
and 23% lower (231) than the reference quartile, while  the highest quintile of a prudent 
diet score from factor analysis was 30% (232). While estimating the survival outcome 
using different diet pattern, a prospective Danish observational study (233) showed that a 
prudent diet pattern obtained by PCA was associated with reduced mortality but index-
based patterns had no significant association. In the EPIC Potsdam study, neither index-
based nor factor analysis had a significant association with hypertension (234).  In the 
SENECA study; the index based scales including Mediterranean Diet Score (MDS), the 
Mediterranean Adequacy Index (MDI) and the Healthy Diet Indicator (HDI) showed 
an inverse association with all-cause mortality (235). 
The current study suggested good evidence of comparability between PCA and CA in 
identifying the diet pattern as seen in other studies (236, 237) despite their different 
approach. Almost two-thirds of individuals in the fruit and vegetable cluster (Cluster I) 
	
	
	 77	
were from the highest quartile of the prudent vegetable pattern identified by PCA having 
highest loading (>0.50) for fruits, vegetables, greens, tomatoes and minimal loadings 
(<0.15) for processed meat, red meat and refined foods. More than 90% of individuals in 
Cluster II, characterized by meat and dairy products, were from the highest quartile of the 
processed meat pattern identified by PCA had higher loading (>0.5) for red meat, cured 
processed meat. Similar was the case with other clusters. Despite good evidence of 
comparability, they aren’t defined by the same foods, which is likely to be the reason for 
differential disease outcome estimate.  
Hypothesis-driven diet patterns give higher weight for fruits and vegetables, which is 
evident by having the majority of individuals in the lowest quartile of DII and the highest 
quartile of Alt-Med and RFS in Cluster I, characterized by fruits and vegetables. 
Correlations between index scores were relatively strong and statistically significant as 
scores were based on similar food recommendations.  An increasing score of Alt-Med, 
RFS and a decrease in DII score are characterized by the higher amount of plant-based 
food (238).   
Indexing systems vary in the definition of optimal diet quality and in their scoring which 
leads difference in their sensitivity to estimate the disease outcome. Differential 
classification of food leads to differential exposure.  RFS accounts for intake of 
vegetables, fruits, healthy protein sources, grains and dairy products but does not 
differentiate between different types of fatty acids or penalize for consumption of foods 
that are not recommended. Alcohol, energy-dense foods and meat products, which are all 
associated with survival outcomes according to the empirical approaches used to 
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investigate the population are not considered in scoring. Hence, RFS is likely to 
underestimate the true association. Further, in the RFS approach, energy cannot be 
adjusted so the effect of body size, physical activity and higher basal metabolic rate 
cannot be taken into account for the analysis (239). Energy adjustment may also help to 
reduce measurement error (229). Alt-Med scoring is based on a high consumption of 
fruits, vegetables, non-refined bread and cereals, legumes and nuts, and a moderate 
consumption of fish, poultry and alcohol. High intakes of red meats, and processed meats 
and saturated fat is penalized during scoring (228). The DII score is based on the 
inflammatory potential of nutrient/food items in response to six inflammatory biomarkers. 
DII may be relevant for diseases associated with chronic inflammation (34). DII is not 
only limited to micro and macronutrients but also incorporates commonly used bioactive 
compounds including flavonoids, spices and tea. Since the current study was based on 
pre-diagnostic diet pattern and dietary-induced inflammation may not have a significant 
role in the survival estimation.  
Multiple reasons could be suggested for the inconsistent results; firstly multiple studies 
have suggested dietary guidelines has been seen strongly related to coronary heart disease 
than to cancer mortality, even when though guidelines are directed toward lowering 
cancer risk (240).  Extensive studies are done on diet-cardiovascular disease then than 
cancer, the role of dietary components in cancer causation is still unclear in many 
instances (231). Secondly, dietary guidelines are more effective for cancer incidence than 
the survival (and therefore mortality) due to the other clinic-pathological factors in 
determining the cancer survival (240). Third, the inconsistency might also be due to 
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missing of some important components and some components in the scales may not have 
the significant association with the cancer risk and survival (231).Also, our 
approximation of the three scales varied slightly than the original scale. Original RFS had 
23 items and was developed for the all-cause mortality rather than cancer-specific 
mortality (32). Likewise, Alt-Med score was developed to assess the variations in the 
biomarkers level (241) and DII index was based on 45 different food parameters whilst 
the current study had only 28 parameters(34).  
Each method has its own strengths and limitations (27). Empirical methods are an initial 
approach and identify diet patterns as they exist in the population (179) and form the 
basis for index-based patterns, but suffer certain limitations: (a) They are based on eating 
behaviour rather than the biological plausibility hence the diet pattern may not exactly 
reflect disease causation theory (179); (b) Even though an association is detected, it may 
not represent beneficial or detrimental eating patterns (242); (c)Lacks limited 
reproducibility across the studies (25) and (d)Includes several arbitrary decisions 
including consolidation of food items into food groups, number of factors/clusters, 
method of rotations and labelling of the patterns/clusters (243).  Index-based patterns are 
based on adherence to the recommendation or guidelines and the foundation of each scale 
varies. Index-based patterns are generally considered by many to be better at estimating 
the disease outcome as compared to empirical patterns due to their inclusion of relevant 
and evidence-based components (234). It has been claimed that results are more 
reproducible across studies. However, they are limited in that they do not capture a full 
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range of diets in scoring (179) and are difficult to use when scores do not vary 
considerably within the population (27) and results vary with the cut-offs defined.   
Strengths and Limitations of study 
This is a prospective follow-up study. Detailed data for the variables (age; sex; marital 
status; Body Mass Index; screening history; use of medications; co-morbidity status; 
history of CRC; smoking; physical activity; diet patterns; alcohol intake; stage and 
location of tumor; chemotherapy status; etc.) are available including the genetic data on 
MSI status. Multiple diet patterns are used for comparison. 
This study has a number of limitations. First, the sample is relatively small, which may 
not offer desirable statistical power and precision in multivariate analysis. Further, cases 
were followed until 2010 only. Recall error and possible bias are likely to exist as the 
cases were asked to remember their diet patterns a year prior to their diagnosis. However, 
we believe the recall bias, if any, could be non-differential, which is likely to attenuate the 
observed association. Although bias may exist and sample size is less, it may have little 
impact on cross-comparison, which is the primary focus of the study. Some cases might 
have changed their diet patterns, lifestyle and behaviour after diagnosis or even in the 
disease induction/latent period; this may lead to possible reverse causation bias, which 
should be explored in future studies. 
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Conclusions 
The present study showed that the estimation of OM and DFS amongst the CRC patients 
varied with the type of diet pattern used.  Hazards ratios for DFS varied from 1.82; 95% 
(CI- 1.07-3.09) for processed meat pattern identified by PCA to HR 2.19; 95% CI 1.03-
4.67 for cluster characterized by meat and dairy products and HR 1.95; 95% CI 1.13-3.37 
for cluster characterized by refined grains, sugar, soft drinks. Only cluster characterized 
by refined grains, sugar, soft drinks had higher risk of OS (HR 2.05; 95% CI 1.18-3.57). 
All the diet indices showed similar null associations with both DFS and OS except Poor 
adherence to altMED increased the risk of all-cause OS (HR 1.62; 95% CI 1.04-2.56).  
On the average estimates were higher for data driven methods than hypothesis driven. 
The variations in the estimated hazards ratios is attributed to the foundation of each 
dietary pattern identified by various approaches. 
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CHAPTER 4: SUMMARY 
 
With the objective of assessing and comparing different diet patterns while estimating the 
CRC risk and Patient’s survival in the Newfoundland Colorectal Cancer Cohort, the 
following study was conducted. The following thesis has two major components.  
The first part investigated the role of diet-mediated inflammation assessed by DII score 
on the risk of CRC. DII score is calculated based on 28 food parameters. Individual’s diet 
was classified either pro-inflammatory or anti-inflammatory based on their dietary intake.  
Results showed that pro-inflammatory diets were associated with increased risk of CRC; 
suggesting an important role of diet-mediated inflammation in colorectal carcinogenesis.  
Diet patterns characterized by higher amounts of fruits, vegetables, whole grains, and 
moderate alcohol intake has lower inflammatory potential and is suggested to reduce the 
chronic inflammation and subsequently reduced the risk of CRC. Diet pattern higher in 
refined and processed foods, red meat, sugary items, oils and fats are pro-inflammatory 
and increases the risk of CRC. 
The second part assessed and compared different diet patterns identified by data and 
hypothesis-driven techniques with CRC patient’s survival. Data from 169-item FFQ were 
used to identify four clusters (identified by CA), three factors (identified by PCA) and 
three indexes (Alt-Med, RFS and DII). Disease estimation varied with the type of diet 
pattern used as an independent variable. Processed meats pattern identified by PCA, 
clusters characterized by meat-dairy-products, total-grains-sugar-soft drinks and poor 
adherence to Mediterranean diet are associated with poor survival.  Prudent vegetable, 
	
	
	 89	
high sugar pattern, adherence to recommended food and dietary inflammation index had 
no significant association with survival. The magnitude of the HRs varied accordingly.   
There are no specific criteria to determine which method is superior. Data-driven patterns 
identify diet patterns as they exist within the population, generate the hypothesis and act 
as the foundation for index-based patterns. Index-based patterns are considered to be 
superior due to the inclusion of relevant and evidence-based food items and, evaluate 
specific dietary goals. Comparing disease outcomes across diet patterns is recommended 
to better understand diet-disease interactions. 
There are some limitations to this study. First, dietary supplements were not considered 
for the study. Second, there are higher chances of recall bias as the food frequency was 
collected before the diagnosis or a year before the date of data collection in controls. The 
major limitation of the second study is the lack of information on the cause of death for 
all deceased participants. The observed differences in OS and DFS could be deaths from 
causes other than CRC. Meanwhile, DII score is a new and fairly effective measure to 
assess the diet mediated-inflammation.  
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Appendix 
Appendix 1: Food Groupings 
FG Food Groups Items 
FG1 Milk Whole Milk, 2% Milk, 2% Evaporated Milk, 1% or Skim Milk, Milk 
Shake 
FG2 Yogurt Yogurt Drink, Yogurt (Plain, 2.4% Fat or More), Yogurt Light  
(Plain, Less than 2.4% Fat), Yogurt (Fruit Flavoured, Frozen,  2.4% 
Fat or More), Yogurt Light ( Fruit Flavoured, Frozen, Less than 2.4%  
FG3 Coffee Coffee, Coffee (Decaffeinated),  
FG4 Tea Tea, Tea (Herbal) 
FG5 Sugar Sugar in Tea and Coffee 
FG6 Soft drinks  Coca Cola, Pepsi, Other Cola,  Diet Soft Drinks, Other Soft Drinks 
(excluding Diet and Cola) 
FG7 Egg Egg (Boiled), Egg (Fried, Scambled, Omelette) 
FG8 Cheese Cream Cheese, Cheese, Cheese, Light ( 6-15% Fat), Cheese, 
Ultralight ( 5% or Less), Cottage or Ricotta Cheese 
FG9 Mixed dishes Soups (Creamed), Pasta (with Meat Sauce), Mixed Dishes with 
Cheese, Pizza (with Meat), Meat Stew, Chili with Meat or Con Carne 
FG10 Red Meat Ground Beef (Regular), Ground Beef (Medium), Ground Beef 
(Lean), Roast Beef, Steak, Pork Chop, Roast Pork, Baked Ham, 
Bacon, Veal, Lamb, Hot Dogs or Wieners, Sausage, Corned Beef, 
Coldcuts, Liver  
FG11 Game Sea-Birds, Seal, Caribou, Moose, Partridge, Other Wild Birds 
FG12 Cured/processed 
red meat 
Baked Ham, Bacon, Hot Dogs or Wieners, Sausage, Corned Beef, 
Coldcuts, Salted/ Dried Meat, Pickled Meat 
FG13 Cured/processed 
meat 
Baked Ham, Bacon, Hot Dogs or Wieners, Sausage, Corned Beef, 
Coldcuts, Fried Chicken, Salted/ Dried Meat, Pickled Meat, Fried 
Fish, Canned Fish, Smoked Fish or Lox, Salted or Dried Fish, 
Pickled Fish 
FG14 Polutry Fried Chicken, Chicken/Turkey, Chicken/Turkey, Skin Removed 
 
FG15 Fish Shellfish, Fried Fish, Fish (Baked or Broiled), Canned Fish, Smoked 
Fish or Lox, Salted or Dried Fish, Pickled Fish 
FG16 Processed Fish Canned Fish, Smoked Fish or Lox, Salted or Dried Fish, Pickled Fish 
	
	
	 115	
FG17 Fruit Juice Orange or Grapefruit Juice, Apple or Grape Juice, Other Fruit Juices 
(Pineapple, Cranberry, etc), Fruit Drink/ Lemonade, Fruit Drinks/ 
Iced Tea 
FG18 Other Fruit Apples, Pears, Grapes, Bananas, Peaches, Plums, Nectarine, Apricot, 
Canteloupe, Watermelon, Honeydew Melon, Mango, Papaya, 
Applesauce, All other Fruit 
FG19 Root Vegetables Potatoes, French Fries and Fried Potatoes, Carrots, Turnips or 
Rutabagas, Other Root Vegetables 
FG20 Cruciferous 
vegetables 
Broccoli, Cabbage, Coleslaw, Cauliflower, Asparagus or Brussel 
Sprouts 
FG21 Other Greens Spinach / other Green Leafy Vegetables, Green Salad (with Lettuce) 
FG22 Beans, peas Peas or Lima Beans, Green Beans, Beans or Lentils, Pea Soup 
FG23 Tomato Sauce Tomatoes (Fresh), Tomatoes (Canned, Pureed, Sauce), Ketchup 
FG24 Other 
Vegetables 
Corn, Cucumber, Onions (Raw or Cooked), Beets (Boiled or Pickled) 
Yellow Squash, Zucchini or eggplant, Sweet Pepper, Bean Sprouts, 
Alfalfa Sprouts, Avocado, Other Vegetables (Celery, Mushrooms 
FG25 Total Cereals 
and Grains 
Bran or Granola Cereals, Whole Wheat Cereals, Cereals,  Not Sugar 
Coated, Hot Cereals, Sugar Coated Cereals, Other Breakfast Cereals, 
Sugar on Cereal, 100% Whole Grain or Dark Bread, 60% Whole 
Grain, Light Rye, White Bread, White Bread Rolls  (Including Hot 
Dog Buns), Whole Wheat Rolls, Crackers, Bran / Oat Muffin, Other 
Muffin, Pancakes, Waffles, Macaroni, Spaghetti, Noodles, etc, Rice, 
Crisp Snacks 
FG26 Whole grains Whole Wheat Cereals, 100% Whole Grain or Dark Bread, 60% 
Whole Grain, Light Rye, Whole Wheat Rolls 
FG27 Desserts and 
sweets 
Cakes, Pies and Tarts, Donuts and Sweet Rolls, Cookies, Ice Cream 
Light or Diet Ice Cream, Pudding, Diet or Light Pudding, JELLO, 
Popsicles, Freezies, Chocolate Bar and Candy, Candy (without 
Chocolate) 
FG28 Vegetable Juice Vegetable Juices 
FG29 Beer Beer or Ale 
FG30 White wine White Wine 
FG31 Red wine Red Wine, Sherry, Port(or Other Fortified Wine) 
FG32 Liquor Liquor 
FG33 Citrus Citrus Fruits 
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FG34 Berries Berries 
FG35 Dried fruit Dried Fruits 
FG36 Canned Fruit Canned Fruit 
FG37 Pies, tarts Pies and Tarts 
FG38 Jam, Jelly Jam, Jelly, Honey, Syrup 
FG39 Pickled 
Vegetables 
Pickles, Relish 
 
Appendix 2: Characteristics of Cluster 
Cluster I (157) Cluster II (37) Cluster 
III(99) 
Cluster IV (253) 
Fruits Dairy products 
(Milk, cheese, 
Yogurt) 
Desserts and 
sweets 
Did not indicate 
any specific 
distinguishing 
food as it had no 
specific 
dominating food 
items.  
 
Fruit and 
Vegetable Juice 
Red and Processed 
meats/fish, game 
meat 
Sugar 
Vegetables, 
greens 
Poultry Soft Drinks 
Beans, peas Mixed Dishes Total grains 
and cereals 
Whole Grains    
Wine (Red, white)    
Fish (Non-
processed) 
   
Numbers in the parenthesis indicates the cluster size 
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Appendix 3: Factor loading and explained variances (VAR) 
Food Groups Processed Meat 
pattern 
Prudent Vegetable 
pattern 
High-Sugar 
Pattern 
Milk  0.19  
Yogurt  0.31  
Sugar  -0.19 0.20 
Tea   0.17 
Coffee 0.17   
Soft Drinks 0.19   
Cheese 0.15 0.21  
Egg 0.21  0.16 
Mixed Dishes 0.31 0.17 0.23 
Red Meat 0.69  0.17 
Cured/processed red 
meat 
0.73  0.21 
Cured/processed meat 0.93   
Game 0.23   
Poultry 0.22 0.27  
Fish 0.58 0.32 -0.22 
Processed Fish 0.50 0.25  
Fruit Juice  0.24 0.23 
Root Vegetables 0.28  0.15 
Cruciferous 
vegetables 
 0.54  
Other Fruits  0.59  
Other greens  0.60 -0.22 
Tomato Sauce  0.50  
Other Vegetables 0.22 0.54  
Beans, Peas 0.15 0.25  
Pickled Vegetables 0.15 0.26 0.15 
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Total Cereals and 
Grains 
0.23 0.38 0.28 
Whole grains  0.33  
Citrus  0.34  
Berries  0.45  
Dried Fruits  0.39  
Vegetable Juice  0.17  
Beer 0.19   
White Wine    
Red Wine    
Liquor    
Desserts and Sweets 0.31  0.63 
Pies, Tarts 0.15  0.54 
Canned Fruits  0.21 0.23 
Jam, Jelly   0.26 
Proportion o f VAR 
explained (%) 
37.79 22.93 11.10 
Cumulative VAR 
Explained (%) 
37.79 62.72 73.82 
Absolute loadings < 0.15 were not listed for simplicity. Those with loadings of 0.50 or 
greater are in bold 
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Appendix 4: Recommended food Score (McCullough ML, et.al; 2002) 
Food Group  Foods Included  
Vegetables Potato, Carrot, Broccoli, Cabbage, Cauliflower, Corn, Peas/lime 
beans, Green beans, Beans/lentils, Spinach, Green Salad, Cucumber, 
Tomato, Canned Tomato, Onions, Beets, Turnip/rutabagas, Root 
Vegetables, Yellow Squash, Zucchini/egg plant, Avocado, Veg Juice 
Fruit Apple/pears, citrus fruits, Berries, Grapes, Bananas, (Peaches, Plums, 
Apricots), Dried Fruits, Apple Sauce, Cantaloupe, Watermelon, 
Honeydew melon, mango, papaya, fruit juice, 
Protein Chicken/turkey without skin, Shell fish, other fish, canned tuna, tofu 
Grains Bran, whole wheat, hot cereal, cereals, dark bread, whole grains 
Dairy Skim milk 
Max. Score 47 (1 point for each item consumed at least weekly) 
 
Appendix 5: Alternate Mediterranean Diet Score (Teresa T Fung, et.al; 2005) 
Vegetables All Vegetables except Potato Greater than median intake (g/d) 
Legumes Tofu, beans, peas, lentils Greater than median intake (g/d) 
Fruit All fruit and Juices Greater than median intake (g/d) 
Nuts Nuts Greater than median intake (g/d) 
Whole Grains Bran, whole wheat, cereals, 
hot cereals, dark bread, 
whole grain 
Greater than median intake (g/d) 
Red and Processed 
Meat 
Red and Processed Meat Less than median intake (g/d) 
Fish All fish and shell fish Greater than median intake (g/d) 
Ratio  Mono-
unsaturated to 
saturated fat 
 Greater than median intake 
Alcohol  5-25g/d 
 
0 point if the criteria is not met 
Maximum Score 9 
